Title: HOUSE BILL No. 2366
Official Title: HOUSE BILL No. 2366
Number of Sections: 1
Source: versions - As introduced
Media Type: application/pdf
Strikethrough Detection: 25 sections found

================================================================================

Section 1:
Session of 2025
By Committee on Health and Human Services
Requested by Kevin Barone, Kansas Naturopathic Doctors Association
2-7
1 AN ACT concerning health and healthcare; relating to the practice of
2 naturopathy; licensure and regulation of naturopathic doctors;
3 broadening the scope of practice of naturopathic doctors; amending
4 K.S.A. 65-7201, 65-7207, 65-7208, 65-7209 and 65-7214 and K.S.A.
5 2022 Supp. 65-1626, 65-4101 and 65-7202 and repealing the existing
6 sections.
7
8 Be it enacted by the Legislature of the State of Kansas:
9 New Section 1. (a) A naturopathic doctor may:
10 (1) Order and perform physical examinations, orifical examinations,
11 excluding endoscopies, and laboratory examinations for diagnostic
12 purposes, including, but not limited to, phlebotomy, clinical laboratory
13 tests, speculum examinations and physiological function tests;
14 (2) order diagnostic imaging studies, including, but not limited to, x-
15 ray, ultrasound, mammogram, bone densitometry, computed tomography,
16 magnetic resonance imaging and electrocardiograms, but a naturopathic
17 doctor shall refer patients to an appropriately licensed and qualified
18 healthcare professional to conduct diagnostic imaging studies and interpret
19 the results;
20 (3) prescribe, recommend or administer: (A) Food, food extracts,
21 nutraceuticals, vitamins, minerals, amino acids, enzymes, whole gland
22 thyroid, botanicals, homeopathic preparations, plant substances, dietary
23 supplements and nonprescription drugs; (B) human cellular and tissue-
24 based products that are not regulated as drugs; (C) healthcare and
25 nutritional counseling, including fertility counseling; (D) dietary therapy,
26 naturopathic physical applications, barrier contraceptive devices and
27 intrauterine insemination; (E) substances authorized for intradermal,
28 subcutaneous, intramuscular, intravenous, ligamentous, tendinous,
29 periarticular or intra-articular administration, including proliferative
30 therapy; (F) biofeedback and neurofeedback therapies; and (G) durable
31 medical equipment and devices;
32 (4) prescribe, administer or dispense: (A) Prescription-only drugs as
33 defined in K.S.A. 65-1626, and amendments thereto; and (B) testosterone,
34 as designated in K.S.A. 65-4109(f)(62), and amendments thereto;
35 (5) perform minor office procedures and naturopathic acupuncture;
HB 2366 2
1 (6) provide naturopathic care to a pregnant patient;
2 (7) utilize routes of administration that include oral, nasal, topical,
3 auricular, ocular, rectal, vaginal, transdermal, intradermal, subcutaneous,
4 intramuscular, ligamentous, tendinous, periarticular, intra-articular and
5 intravenous; and
6 (8) utilize non-diagnostic ultrasound in the performance of services.
7 (b) A naturopathic doctor shall not:
8 (1) Perform surgery;
9 (2) perform labor, delivery or any procedure involving the
10 reproductive organs of a pregnant patient;
11 (3) administer ionizing radiation for therapeutic purposes;
12 (4) use general or spinal anesthetics;
13 (5) administer, conduct or interpret the results of diagnostic imaging
14 studies except as authorized by this act;
15 (6) claim to practice any licensed healthcare profession or system
16 other than naturopathic medicine, unless holding a separate license in that
17 profession;
18 (7) perform procedures involving the termination of a pregnancy; or
19 (8) prescribe, administer or dispense any controlled substances not
20 authorized by this act.
21 New Sec. 2. A naturopathic doctor who prescribes pursuant to section
22 1(a)(3) and (a)(4), and amendments thereto, shall:
23 (a) Record each prescription order in writing, which may include an
24 electronically recorded and transmitted communication. The order shall
25 include the name, address and telephone number of the naturopathic
26 doctor;
27 (b) prescribe only when the naturopathic doctor has adequate
28 education, training and experience to safely manage the medical regimen;
29 and
30 (c) register with the United States drug enforcement administration in
31 order to prescribe controlled substances authorized by this act.
32 New Sec. 3. (a) The practice of naturopathy shall not include the
33 following:
34 (1) Persons whose professional services are performed under the
35 supervision or by order of or referral from a naturopathic doctor licensed
36 under the naturopathic doctor licensure act;
37 (2) persons licensed to engage in the practice of naturopathic
38 medicine in another state, territory or the District of Columbia when called
39 into this state in consultation with naturopathic doctors licensed in this
40 state; and
41 (3) practitioners of the healing arts licensed under the healing arts act
42 and practicing their professions or persons performing services pursuant to
43 the delegation of a licensee under K.S.A. 65-2872(g), and amendments
HB 2366 3
1 thereto.
2 (b) Nothing in this act shall be construed to restrict any person
3 licensed or regulated by the state of Kansas from engaging in the
4 profession or practice for which they are licensed or regulated.
5 New Sec. 4. (a) Every naturopathic doctor shall maintain a record for
6 each patient for whom a professional service is rendered, including:
7 Documentation of dates of professional services, pertinent and significant
8 information regarding the patient's condition, examinations and testing, all
9 findings and results, diagnosis and treatment performed or recommended,
10 patient progress and all patient records received from other providers.
11 (b) Every naturopathic doctor shall maintain a patient's record for a
12 minimum of 10 years from the date the licensee provided the professional
13 service recorded.
14 New Sec. 5. If any provision of the naturopathic doctor licensure act
15 or application thereof to any person or circumstance is held invalid, such
16 invalidity shall not affect other provisions or applications that can be given
17 effect without the invalid provision or application, and to this end, the
18 provisions of the naturopathic doctor licensure act are declared to be
19 severable.
20 Sec. 6. K.S.A. 2024 Supp. 65-1626 is hereby amended to read as
21 follows: 65-1626. As used in the pharmacy act of the state of Kansas:
22 (a) "Address" means, with respect to prescriptions, the physical
23 address where a patient resides, including street address, city and state.
24 (b) "Administer" means the direct application of a drug, whether by
25 injection, inhalation, ingestion or any other means, to the body of a patient
26 or research subject by:
27 (1) A practitioner or pursuant to the lawful direction of a practitioner;
28 (2) the patient or research subject at the direction and in the presence
29 of the practitioner; or
30 (3) a pharmacist as authorized in K.S.A. 65-1635a, and amendments
31 thereto, or K.S.A. 2024 Supp. 65-16,129, and amendments thereto.
32 (c) "Agent" means an authorized person who acts on behalf of or at
33 the direction of a manufacturer, repackager, wholesale distributor, third-
34 party logistics provider or dispenser but does not include a common
35 carrier, public warehouseman or employee of the carrier or warehouseman
36 when acting in the usual and lawful course of the carrier's or
37 warehouseman's business.
38 (d) "Automated dispensing system" means a robotic or mechanical
39 system controlled by a computer that:
40 (1) Performs operations or activities, other than compounding or
41 administration, relative to the storage, packaging, labeling, dispensing or
42 distribution of drugs;
43 (2) collects, controls and maintains all transaction information; and
HB 2366 4
1 (3) operates in accordance with the board's rules and regulations.
2 (e) "Biological product" means the same as defined in 42 U.S.C. §
3 262(i), as in effect on January 1, 2017.
4 (f) "Board" means the state board of pharmacy created by K.S.A. 74-
5 1603, and amendments thereto.
6 (g) "Brand exchange," in the case of a drug prescribed, means the
7 dispensing of a different drug product of the same dosage form and
8 strength and of the same generic name as the brand name drug product
9 prescribed, and in the case of a biological product prescribed, means the
10 dispensing of an interchangeable biological product.
11 (h) "Brand name" means the registered trademark name given to a
12 drug product by its manufacturer, labeler or distributor.
13 (i) "Co-licensed partner" means a person or pharmaceutical
14 manufacturer that has entered into an agreement with another
15 pharmaceutical manufacturer or an affiliate of the manufacturer to engage
16 in a business activity or occupation related to the manufacture or
17 distribution of a product.
18 (j) "Common carrier" means any person who undertakes, whether
19 directly or by any other arrangement, to transport property, including
20 drugs, for compensation.
21 (k) (1) "Compounding" means the combining of components into a
22 compounded preparation under either of the following conditions:
23 (A) As the result of a practitioner's prescription drug order or
24 initiative based on the practitioner-patient-pharmacist relationship in the
25 course of professional practice to meet the specialized medical need of an
26 individual patient of the practitioner that cannot be filled by an FDA-
27 approved drug; or
28 (B) for the purpose of, or incidental to, research, teaching or chemical
29 analysis, and not for sale or dispensing.
30 (2) Compounding includes the preparation of drugs or devices in
31 anticipation of receiving prescription drug orders based on routine,
32 regularly observed prescribing patterns.
33 (3) Compounding does not include reconstituting any mixed drug
34 according to the FDA-approved labeling for the drug.
35 (l) "Current good manufacturing practices" or "CGMP" means the
36 requirements for ensuring that drugs and drug products are consistently
37 manufactured, repackaged, produced, stored and dispensed in accordance
38 with 21 C.F.R. §§ 207, 210 and 211.
39 (m) "DEA" means the United States department of justice, drug
40 enforcement administration.
41 (n) "Deliver" or "delivery" means the actual, constructive or
42 attempted transfer from one person to another of any drug whether or not
43 an agency relationship exists.
HB 2366 5
1 (o) "Device" means an instrument, apparatus, implement, machine,
2 contrivance, implant, in vitro reagent or other similar or related article,
3 including a component part or accessory that:
4 (1) (A) Is recognized in the official national formulary, or the United
5 States pharmacopoeia, or any supplement thereof;
6 (B) is intended for use in the diagnosis of disease or other conditions;
7 (C) is used for the cure, mitigation, treatment or prevention of disease
8 in human or other animals; or
9 (D) is intended to affect the structure or any function of the body of
10 human or other animals; and
11 (2) (A) does not achieve its primary intended purposes through
12 chemical action within or on the body of human or other animals; and
13 (B) is not dependent upon being metabolized for the achievement of
14 any of its primary intended purposes.
15 (p) "Direct supervision" means the process by which the responsible
16 pharmacist shall observe and direct the activities of a pharmacist intern or
17 pharmacy technician, be readily and immediately available at all time
18 activities are performed, provide personal assistance, direction and
19 approval throughout the time the activities are performed and complete the
20 final check before dispensing.
21 (q) "Dispense" or "dispensing" means to deliver prescription
22 medication to the ultimate user or research subject by or pursuant to the
23 lawful order of a practitioner or pursuant to the prescription of a mid-level
24 practitioner, including, but not limited to, delivering prescription
25 medication to a patient by mail, common carrier, personal delivery or
26 third-party delivery to any location requested by the patient.
27 (r) "Dispenser" means:
28 (1) A practitioner or pharmacist who dispenses prescription drugs or
29 devices or a physician assistant who has authority to dispense prescription-
30 only drugs in accordance with K.S.A. 65-28a08(b), and amendments
31 thereto; or
32 (2) a retail pharmacy, hospital pharmacy or group of pharmacies
33 under common ownership and control that do not act as a wholesale
34 distributor.
35 (s) "Distribute" or "distribution" means to deliver, offer to deliver,
36 sell, offer to sell, purchase, trade, transfer, broker, give away, handle, store
37 or receive, other than by administering or dispensing, any product, but
38 does not include dispensing a product pursuant to a prescription executed
39 in accordance with 21 U.S.C. § 353 or the dispensing of a product
40 approved under 21 U.S.C. § 360b.
41 (t) "Distributor" means a person or entity that distributes a drug or
42 device.
43 (u) "Diversion" means the transfer of a controlled substance from a
HB 2366 6
1 lawful to an unlawful channel of distribution or use.
2 (v) "Drop shipment" means the sale, by a manufacturer, repackager or
3 exclusive distributor, of the manufacturer's prescription drug to a
4 wholesale distributor whereby the wholesale distributor takes title but not
5 possession of such prescription drug and the wholesale distributor invoices
6 the dispenser, and the dispenser receives delivery of the prescription drug
7 directly from the manufacturer, repackager, third-party logistics provider
8 or exclusive distributor, of such prescription drug.
9 (w) "Drug" means articles:
10 (1) Recognized in the official United States pharmacopeia, or other
11 such official compendiums of the United States, or official national
12 formulary, or any supplement to any of them;
13 (2) intended for use in the diagnosis, cure, mitigation, treatment or
14 prevention of disease in human or other animals;
15 (3) other than food, intended to affect the structure or any function of
16 the body of human or other animals; and
17 (4) intended for use as a component of any articles specified in
18 paragraph (1), (2) or (3); but does not include devices or their components,
19 parts or accessories, except that the term "drug" does not include
20 amygdalin (laetrile) or any livestock remedy, if such livestock remedy had
21 been registered in accordance with the provisions of article 5 of chapter 47
22 of the Kansas Statutes Annotated, prior to its repeal.
23 (x) "Durable medical equipment" means equipment that:
24 (1) Provides therapeutic benefits or enables an individual to perform
25 certain tasks that the individual is unable to otherwise undertake due to
26 certain medical conditions or illnesses;
27 (2) is primarily and customarily used to serve a medical purpose;
28 (3) generally is not useful to a person in the absence of an illness or
29 injury;
30 (4) can withstand repeated use;
31 (5) is appropriate for use in the home, long-term care facility or
32 medical care facility, but may be transported to other locations to allow the
33 individual to complete instrumental activities of daily living that are more
34 complex tasks required for independent living; and
35 (6) may include devices and medical supplies or other similar
36 equipment determined by the board in rules and regulations adopted by the
37 board.
38 (y) "Electronic prescription" means an electronically prepared
39 prescription that is authorized and transmitted from the prescriber to the
40 pharmacy by means of electronic transmission.
41 (z) "Electronic prescription application" means software that is used
42 to create electronic prescriptions and that is intended to be installed on the
43 prescriber's computers and servers where access and records are controlled
HB 2366 7
1 by the prescriber.
2 (aa) "Electronic signature" means a confidential personalized digital
3 key, code, number or other method for secure electronic data transmissions
4 that identifies a particular person as the source of the message,
5 authenticates the signatory of the message and indicates the person's
6 approval of the information contained in the transmission.
7 (bb) "Electronic transmission" means the transmission of an
8 electronic prescription, formatted as an electronic data file, from a
9 prescriber's electronic prescription application to a pharmacy's computer,
10 where the data file is imported into the pharmacy prescription application.
11 (cc) "Electronically prepared prescription" means a prescription that
12 is generated using an electronic prescription application.
13 (dd) "Exclusive distributor" means the wholesale distributor that
14 directly purchased the product from the manufacturer and is the sole
15 distributor of that manufacturer's product to a subsequent repackager,
16 wholesale distributor or dispenser.
17 (ee) "FDA" means the United States department of health and human
18 services, food and drug administration.
19 (ff) "Facsimile transmission" or "fax transmission" means the
20 transmission of a digital image of a prescription from the prescriber or the
21 prescriber's agent to the pharmacy. "Facsimile transmission" includes, but
22 is not limited to, transmission of a written prescription between the
23 prescriber's fax machine and the pharmacy's fax machine; transmission of
24 an electronically prepared prescription from the prescriber's electronic
25 prescription application to the pharmacy's fax machine, computer or
26 printer; or transmission of an electronically prepared prescription from the
27 prescriber's fax machine to the pharmacy's fax machine, computer or
28 printer.
29 (gg) "Generic name" means the established chemical name or official
30 name of a drug or drug product.
31 (hh) "Healthcare entity" means any person that provides diagnostic,
32 medical, surgical or dental treatment or rehabilitative care but does not
33 include any retail pharmacy or wholesale distributor.
34 (ii) (1) "Institutional drug room" means any location where
35 prescription-only drugs are stored and from which prescription-only drugs
36 are administered or dispensed and that is maintained or operated for the
37 purpose of providing the drug needs of:
38 (A) Inmates of a jail or correctional institution or facility;
39 (B) residents of a juvenile correctional facility or juvenile detention
40 facility, as defined in K.S.A. 38-2302, and amendments thereto;
41 (C) students of a public or private university or college, a community
42 college or any other institution of higher learning that is located in Kansas;
43 (D) employees of a business or other employer; or
HB 2366 8
1 (E) persons receiving inpatient hospice services.
2 (2) "Institutional drug room" does not include:
3 (A) Any registered pharmacy;
4 (B) any office of a practitioner; or
5 (C) a location where no prescription-only drugs are dispensed and no
6 prescription-only drugs other than individual prescriptions are stored or
7 administered.
8 (jj) "Interchangeable biological product" means a biological product
9 that the FDA has identified in the "purple book: lists of licensed biological
10 products with reference product exclusivity and biosimilarity or
11 interchangeability evaluations" as meeting the standards for
12 "interchangeability" as defined in 42 U.S.C. § 262(k), as in effect on
13 January 1, 2017.
14 (kk) "Intracompany transaction" means any transaction or transfer
15 between any division, subsidiary, parent or affiliated or related company
16 under common ownership or control of a corporate entity, or any
17 transaction or transfer between co-licensed partners.
18 (ll) "Label" means a display of written, printed or graphic matter
19 upon the immediate container of any drug.
20 (mm) "Labeling" means the process of preparing and affixing a label
21 to any drug container, exclusive of the labeling by a manufacturer, packer
22 or distributor of a non-prescription drug or commercially packaged legend
23 drug.
24 (nn) "Fingerprint candidate" means a person who has made an
25 original application for or reinstatement of any license, registration, permit
26 or certificate under this act or a person who currently holds a license,
27 registration, permit or certificate under this act.
28 (oo) "Long-term care facility" means "nursing facility," as defined in
29 K.S.A. 39-923, and amendments thereto.
30 (pp) "Medical care facility" means the same as defined in K.S.A. 65-
31 425, and amendments thereto, and also includes psychiatric hospitals and
32 psychiatric residential treatment facilities as defined by K.S.A. 39-2002,
33 and amendments thereto.
34 (qq) "Manufacture" means the production, preparation, propagation,
35 compounding, conversion or processing of a drug either directly or
36 indirectly by extraction from substances of natural origin, independently
37 by means of chemical or biological synthesis or by a combination of
38 extraction and chemical or biological synthesis or the packaging or
39 repackaging of the drug or labeling or relabeling of its container, except
40 that this term does not include the preparation or compounding of a drug
41 by an individual for the individual's own use or the preparation,
42 compounding, packaging or labeling of a drug by:
43 (1) A practitioner or a practitioner's authorized agent incident to such
HB 2366 9
1 practitioner's administering or dispensing of a drug in the course of the
2 practitioner's professional practice;
3 (2) a practitioner, by a practitioner's authorized agent or under a
4 practitioner's supervision for the purpose of, or as an incident to, research,
5 teaching or chemical analysis and not for sale; or
6 (3) a pharmacist or the pharmacist's authorized agent acting under the
7 direct supervision of the pharmacist for the purpose of, or incident to, the
8 dispensing of a drug by the pharmacist.
9 (rr) "Manufacturer" means:
10 (1) A person that holds an application approved under section 505 of
11 the federal food, drug and cosmetic act or a license issued under section
12 351 of the federal public health service act for such drug or, if such drug is
13 not the subject of an approved application or license, the person who
14 manufactured the drug;
15 (2) a co-licensed partner of the person described in paragraph (1) that
16 obtains the drug directly from a person described in paragraph (1) or (3);
17 or
18 (3) an affiliate of a person described in paragraph (1) or (2) that
19 receives the product directly from a person described in paragraph (1) or
20 (2).
21 (ss) "Medication order" means a written or oral order by a prescriber
22 or the prescriber's authorized agent for administration of a drug or device
23 to a patient in a Kansas licensed medical care facility or in a Kansas
24 licensed nursing facility or nursing facility for mental health, as such terms
25 are defined by K.S.A. 39-923, and amendments thereto.
26 (tt) "Mid-level practitioner" means a certified nurse-midwife
27 engaging in the independent practice of midwifery under the independent
28 practice of midwifery act, an advanced practice registered nurse issued a
29 license pursuant to K.S.A. 65-1131, and amendments thereto, who has
30 authority to prescribe drugs under K.S.A. 65-1130, and amendments
31 thereto, or a physician assistant licensed pursuant to the physician assistant
32 licensure act who has authority to prescribe drugs pursuant to a written
33 agreement with a supervising physician under K.S.A. 65-28a08, and
34 amendments thereto.
35 (uu) "Nonresident pharmacy" means a pharmacy located outside of
36 Kansas.
37 (vv) "Outsourcing facility" means a facility at one geographic
38 location or address that is engaged in the compounding of sterile drugs and
39 has registered with the FDA as an outsourcing facility pursuant to 21
40 U.S.C. § 353b.
41 (ww) "Person" means individual, corporation, government,
42 governmental subdivision or agency, partnership, association or any other
43 legal entity.
HB 2366 10
1 (xx) "Pharmacist" means any natural person licensed under this act to
2 practice pharmacy.
3 (yy) "Pharmacist-in-charge" means the pharmacist who is responsible
4 to the board for a registered establishment's compliance with the laws and
5 regulations of this state pertaining to the practice of pharmacy,
6 manufacturing of drugs and the distribution of drugs. The pharmacist-in-
7 charge shall supervise such establishment on a full-time or a part-time
8 basis and perform such other duties relating to supervision of a registered
9 establishment as may be prescribed by the board by rules and regulations.
10 Nothing in this definition shall relieve other pharmacists or persons from
11 their responsibility to comply with state and federal laws and regulations.
12 (zz) "Pharmacist intern" or "intern" means:
13 (1) A student currently enrolled in and in good standing with an
14 accredited pharmacy program;
15 (2) a graduate of an accredited pharmacy program serving an
16 internship; or
17 (3) a graduate of a pharmacy program located outside of the United
18 States that is not accredited and who has successfully passed equivalency
19 examinations approved by the board.
20 (aaa) "Pharmacy," "drugstore" or "apothecary" means premises,
21 laboratory, area or other place, including any electronic medium:
22 (1) Where drugs are offered for sale where the profession of
23 pharmacy is practiced and where prescriptions are compounded and
24 dispensed;
25 (2) that has displayed upon it or within it the words "pharmacist,"
26 "pharmaceutical chemist," "pharmacy," "apothecary," "drugstore,"
27 "druggist," "drugs," "drug sundries" or any of these words or combinations
28 of these words or words of similar import in any language or on any sign
29 containing any of these words as used in the context of health, medical or
30 pharmaceutical care or services; or
31 (3) where the characteristic symbols of pharmacy or the characteristic
32 prescription sign "Rx" may be exhibited in the context of health, medical
33 or pharmaceutical care or services. As used in this subsection, premises
34 refers only to the portion of any building or structure leased, used or
35 controlled by the licensee in the conduct of the business registered by the
36 board at the address for which the registration was issued.
37 (bbb) "Pharmacy prescription application" means software that is
38 used to process prescription information and is either installed on a
39 pharmacy's computers or servers and is controlled by the pharmacy or is
40 maintained on the servers of an entity that sells electronic pharmacy
41 prescription applications as a hosted service where the entity controls
42 access to the application and maintains the software and records on its
43 server.
HB 2366 11
1 (ccc) "Pharmacy technician" means an individual who, under the
2 direct supervision and control of a pharmacist, may perform packaging,
3 manipulative, repetitive or other nondiscretionary tasks related to the
4 processing of a prescription or medication order and who assists the
5 pharmacist in the performance of pharmacy-related duties, but who does
6 not perform duties restricted to a pharmacist.
7 (ddd) "Practitioner" means a person licensed to practice medicine and
8 surgery, dentist, podiatrist, veterinarian, optometrist, naturopathic doctor
9 or scientific investigator or other person authorized by law to use a
10 prescription-only drug in teaching or chemical analysis or to conduct
11 research with respect to a prescription-only drug.
12 (eee) "Preceptor" means a licensed pharmacist who possesses at least
13 two years' experience as a pharmacist and who supervises and is
14 responsible for the actions of pharmacist interns obtaining pharmaceutical
15 experience.
16 (fff) "Prescriber" means a practitioner or a mid-level practitioner.
17 (ggg) "Prescription" or "prescription order" means the front and back
18 of a lawful written, electronic or facsimile order from a prescriber or an
19 oral order from a prescriber or the prescriber's authorized agent that
20 communicates the prescriber's instructions for a prescription drug or
21 device to be dispensed.
22 (hhh) "Prescription medication" means any drug, including label and
23 container according to context, that is dispensed pursuant to a prescription
24 order.
25 (iii) "Prescription-only drug" means any drug whether intended for
26 use by human or animal, required by federal or state law, including 21
27 U.S.C. § 353, to be dispensed only pursuant to a written or oral
28 prescription or order of a practitioner or is restricted to use by practitioners
29 only.
30 (jjj) "Probation" means the practice or operation under a temporary
31 license, registration or permit or a conditional license, registration or
32 permit of a business or profession for which a license, registration or
33 permit is granted by the board under the provisions of the pharmacy act of
34 the state of Kansas requiring certain actions to be accomplished or certain
35 actions not to occur before a regular license, registration or permit is
36 issued.
37 (lll) "Product" means the same as defined by part H of the federal
38 drug supply chain security act, 21 U.S.C. § 351 et seq. and 21 U.S.C. §
39 360eee.
40 (mmm) "Professional incompetency" means:
41 (1) One or more instances involving failure to adhere to the
42 applicable standard of pharmaceutical care to a degree that constitutes
43 gross negligence, as determined by the board;
HB 2366 12
1 (2) repeated instances involving failure to adhere to the applicable
2 standard of pharmaceutical care to a degree that constitutes ordinary
3 negligence, as determined by the board; or
4 (3) a pattern of pharmacy practice or other behavior that demonstrates
5 a manifest incapacity or incompetence to practice pharmacy.
6 (nnn) "Readily retrievable" or "readily available" means that records
7 kept in hard copy or by automatic data processing applications or other
8 electronic or mechanized record-keeping systems can be separated out
9 from all other records quickly and easily during an inspection or
10 investigation, or within a reasonable time not to exceed 48 hours of a
11 written request from the board or other authorized agent.
12 (ooo) "Repackage" means changing the container, wrapper, quantity
13 or label of a drug to further the distribution of the drug.
14 (ppp) "Repackager" means a person who owns or operates a facility
15 that repackages.
16 (qqq) "Retail dealer" means a person selling at retail nonprescription
17 drugs that are prepackaged, fully prepared by the manufacturer or
18 distributor for use by the consumer and labeled in accordance with the
19 requirements of the state and federal food, drug and cosmetic acts. Such
20 nonprescription drugs shall not include: (1) A controlled substance; (2) a
21 prescription-only drug; or (3) a drug intended for human use by
22 hypodermic injection.
23 (rrr) "Reverse distributor" means a person who owns or operates an
24 establishment that disposes of or otherwise processes saleable or
25 nonsaleable products received from an authorized trading partner such that
26 the product may be processed for credit to the purchaser, manufacturer or
27 seller or disposed of for no further distribution.
28 (sss) "Secretary" means the executive secretary of the board.
29 (ttt) "Third-party logistics provider" means an entity that provides or
30 coordinates warehousing or other logistic services of a product in interstate
31 commerce on behalf of a manufacturer, wholesale distributor or dispenser,
32 but does not take ownership of the product or have responsibility to direct
33 the sale or disposition of the product.
34 (uuu) "Trading partner" means:
35 (1) A manufacturer, repackager, wholesale distributor or dispenser
36 from whom a manufacturer, repackager, wholesale distributor or dispenser
37 accepts direct ownership of a product or to whom a manufacturer,
38 repackager, wholesale distributor or dispenser transfers direct ownership of
39 a product; or
40 (2) a third-party logistics provider from whom a manufacturer,
41 repackager, wholesale distributor or dispenser accepts direct possession of
42 a product or to whom a manufacturer, repackager, wholesale distributor or
43 dispenser transfers direct possession of a product.
HB 2366 13
1 (vvv) "Transaction" means the transfer of product between persons in
2 which a change of ownership occurs.
3 (www) "Unprofessional conduct" means:
4 (1) Fraud in securing a registration or permit;
5 (2) intentional adulteration or mislabeling of any drug, medicine,
6 chemical or poison;
7 (3) causing any drug, medicine, chemical or poison to be adulterated
8 or mislabeled, knowing the same to be adulterated or mislabeled;
9 (4) intentionally falsifying or altering records or prescriptions;
10 (5) unlawful possession of drugs and unlawful diversion of drugs to
11 others;
12 (6) willful betrayal of confidential information under K.S.A. 65-1654,
13 and amendments thereto;
14 (7) conduct likely to deceive, defraud or harm the public;
15 (8) making a false or misleading statement regarding the licensee's
16 professional practice or the efficacy or value of a drug;
17 (9) commission of any act of sexual abuse, misconduct or
18 exploitation related to the licensee's professional practice; or
19 (10) performing unnecessary tests, examinations or services that have
20 no legitimate pharmaceutical purpose.
21 (xxx) "Vaccination protocol" means a written protocol, agreed to and
22 signed by a pharmacist and a person licensed to practice medicine and
23 surgery by the state board of healing arts, that establishes procedures and
24 recordkeeping and reporting requirements for administering a vaccine by
25 the pharmacist for a period of time specified therein, not to exceed two
26 years.
27 (yyy) "Valid prescription order" means a prescription that is issued
28 for a legitimate medical purpose by an individual prescriber licensed by
29 law to administer and prescribe drugs and acting in the usual course of
30 such prescriber's professional practice. A prescription issued solely on the
31 basis of an internet-based questionnaire or consultation without an
32 appropriate prescriber-patient relationship is not a valid prescription order.
33 (zzz) "Veterinary medical teaching hospital pharmacy" means any
34 location where prescription-only drugs are stored as part of an accredited
35 college of veterinary medicine and from which prescription-only drugs are
36 distributed for use in treatment of or administration to a nonhuman.
37 (aaaa) "Virtual manufacturer" means an entity that engages in the
38 manufacture of a drug or device for which it:
39 (1) Owns the new drug application or abbreviated new drug
40 application number, if a prescription drug;
41 (2) owns the unique device identification number, as available, for a
42 prescription device;
43 (3) contracts with a contract manufacturing organization for the
HB 2366 14
1 physical manufacture of the drug or device;
2 (4) is not involved in the physical manufacture of the drug or device;
3 and
4 (5) does not store or take physical possession of the drug or device.
5 (bbbb) "Virtual wholesale distributor" means a wholesale distributor
6 that sells, brokers or transfers a drug or device but never physically
7 possesses the product.
8 (cccc) "Wholesale distributor" means any person engaged in
9 wholesale distribution or reverse distribution of drugs or devices, other
10 than a manufacturer, co-licensed partner or third-party logistics provider.
11 (dddd) "Wholesale distribution" means the distribution or receipt of
12 drugs or devices to or by persons other than consumers or patients, in
13 which a change of ownership occurs. "Wholesale distribution" does not
14 include:
15 (1) The dispensing of a drug or device pursuant to a prescription;
16 (2) the distribution of a drug or device or an offer to distribute a drug
17 or device for emergency medical reasons, including a public health
18 emergency declaration pursuant to section 319 of the public health service
19 act, except that, for purposes of this paragraph, a drug or device shortage
20 not caused by a public health emergency shall not constitute an emergency
21 medical reason;
22 (3) intracompany distribution;
23 (4) the distribution of a drug or device, or an offer to distribute a drug
24 or device, among hospitals or other healthcare entities under common
25 control;
26 (5) the distribution of a drug or device, or the offer to distribute a
27 drug or device, by a charitable organization described in section 501(c)(3)
28 of the internal revenue code of 1986 to a nonprofit affiliate of the
29 organization to the extent otherwise permitted by law;
30 (6) the distribution of an intravenous drug used to maintain the
31 equilibrium of water and minerals in the body, such as dialysis solutions;
32 or
33 (7) the sale or transfer from a retail pharmacy of expired, damaged,
34 returned or recalled prescription drugs to the original manufacturer,
35 originating wholesale distributor or to a reverse distributor registered in
36 accordance with the board's rules and regulations.
37 Sec. 7. K.S.A. 2022 Supp. 65-4101 is hereby amended to read as
38 follows: 65-4101. As used in this act:
39 (a) "Administer" means the direct application of a controlled
40 substance, whether by injection, inhalation, ingestion or any other means,
41 to the body of a patient or research subject by:
42 (1) A practitioner or pursuant to the lawful direction of a practitioner;
43 or
HB 2366 15
1 (2) the patient or research subject at the direction and in the presence
2 of the practitioner.
3 (b) "Agent" means an authorized person who acts on behalf of or at
4 the direction of a manufacturer, distributor or dispenser. It does not include
5 a common carrier, public warehouseman or employee of the carrier or
6 warehouseman.
7 (c) "Application service provider" means an entity that sells
8 electronic prescription or pharmacy prescription applications as a hosted
9 service where the entity controls access to the application and maintains
10 the software and records on its server.
11 (d) "Board" means the state board of pharmacy.
12 (e) "Bureau" means the bureau of narcotics and dangerous drugs,
13 United States department of justice, or its successor agency.
14 (f) "Controlled substance" means any drug, substance or immediate
15 precursor included in any of the schedules designated in K.S.A. 65-4105,
16 65-4107, 65-4109, 65-4111 and 65-4113, and amendments thereto.
17 (g) (1) "Controlled substance analog" means a substance that is
18 intended for human consumption, and at least one of the following:
19 (A) The chemical structure of the substance is substantially similar to
20 the chemical structure of a controlled substance listed in or added to the
21 schedules designated in K.S.A. 65-4105 or 65-4107, and amendments
22 thereto;
23 (B) the substance has a stimulant, depressant or hallucinogenic effect
24 on the central nervous system substantially similar to the stimulant,
25 depressant or hallucinogenic effect on the central nervous system of a
26 controlled substance included in the schedules designated in K.S.A. 65-
27 4105 or 65-4107, and amendments thereto; or
28 (C) with respect to a particular individual, such individual represents
29 or intends the substance to have a stimulant, depressant or hallucinogenic
30 effect on the central nervous system substantially similar to the stimulant,
31 depressant or hallucinogenic effect on the central nervous system of a
32 controlled substance included in the schedules designated in K.S.A. 65-
33 4105 or 65-4107, and amendments thereto.
34 (2) "Controlled substance analog" does not include:
35 (A) A controlled substance;
36 (B) a substance for which there is an approved new drug application;
37 or
38 (C) a substance with respect to which an exemption is in effect for
39 investigational use by a particular person under section 505 of the federal
40 food, drug and cosmetic act, 21 U.S.C. § 355, to the extent conduct with
41 respect to the substance is permitted by the exemption.
42 (h) "Counterfeit substance" means a controlled substance that, or the
43 container or labeling of which, without authorization bears the trademark,
HB 2366 16
1 trade name or other identifying mark, imprint, number or device or any
2 likeness thereof of a manufacturer, distributor or dispenser other than the
3 person who in fact manufactured, distributed or dispensed the substance.
4 (i) "Cultivate" means the planting or promotion of growth of five or
5 more plants that contain or can produce controlled substances.
6 (j) "DEA" means the U.S. United States department of justice, drug
7 enforcement administration.
8 (k) "Deliver" or "delivery" means the actual, constructive or
9 attempted transfer from one person to another of a controlled substance,
10 whether or not there is an agency relationship.
11 (l) "Dispense" means to deliver a controlled substance to an ultimate
12 user or research subject by or pursuant to the lawful order of a practitioner,
13 including the packaging, labeling or compounding necessary to prepare the
14 substance for that delivery, or pursuant to the prescription of a mid-level
15 practitioner.
16 (m) "Dispenser" means a practitioner or pharmacist who dispenses, or
17 a physician assistant who has authority to dispense prescription-only drugs
18 in accordance with K.S.A. 65-28a08(b), and amendments thereto.
19 (n) "Distribute" means to deliver other than by administering or
20 dispensing a controlled substance.
21 (o) "Distributor" means a person who distributes.
22 (p) (1) "Drug" means substances:
23 (A) Substances Recognized as drugs in the official United States
24 pharmacopeia, official homeopathic pharmacopoeia of the United States or
25 official national formulary or any supplement to any of them;
26 (B) substances intended for use in the diagnosis, cure, mitigation,
27 treatment or prevention of disease in human or animals;
28 (C) substances (other than food) intended to affect the structure or
29 any function of the body of human or animals; and
30 (D) substances intended for use as a component of any article
31 specified in subparagraph (A), (B) or (C).
32 (2) "Drug" does not include devices or their components, parts or
33 accessories.
34 (q) "Immediate precursor" means a substance that the board has
35 found to be and by rule and regulation designates as being the principal
36 compound commonly used or produced primarily for use and that is an
37 immediate chemical intermediary used or likely to be used in the
38 manufacture of a controlled substance, the control of which is necessary to
39 prevent, curtail or limit manufacture.
40 (r) "Electronic prescription" means an electronically prepared
41 prescription that is authorized and transmitted from the prescriber to the
42 pharmacy by means of electronic transmission.
43 (s) "Electronic prescription application" means software that is used
HB 2366 17
1 to create electronic prescriptions and that is intended to be installed on the
2 prescriber's computers and servers where access and records are controlled
3 by the prescriber.
4 (t) "Electronic signature" means a confidential personalized digital
5 key, code, number or other method for secure electronic data transmissions
6 that identifies a particular person as the source of the message,
7 authenticates the signatory of the message and indicates the person's
8 approval of the information contained in the transmission.
9 (u) "Electronic transmission" means the transmission of an electronic
10 prescription, formatted as an electronic data file, from a prescriber's
11 electronic prescription application to a pharmacy's computer, where the
12 data file is imported into the pharmacy prescription application.
13 (v) "Electronically prepared prescription" means a prescription that is
14 generated using an electronic prescription application.
15 (w) "Facsimile transmission" or "fax transmission" means the
16 transmission of a digital image of a prescription from the prescriber or the
17 prescriber's agent to the pharmacy. "Facsimile transmission" includes, but
18 is not limited to, transmission of a written prescription between the
19 prescriber's fax machine and the pharmacy's fax machine; transmission of
20 an electronically prepared prescription from the prescriber's electronic
21 prescription application to the pharmacy's fax machine, computer or
22 printer; or transmission of an electronically prepared prescription from the
23 prescriber's fax machine to the pharmacy's fax machine, computer or
24 printer.
25 (x) "Intermediary" means any technology system that receives and
26 transmits an electronic prescription between the prescriber and the
27 pharmacy.
28 (y) "Isomer" means all enantiomers and diastereomers.
29 (z) "Manufacture" means the production, preparation, propagation,
30 compounding, conversion or processing of a controlled substance either
31 directly or indirectly or by extraction from substances of natural origin or
32 independently by means of chemical synthesis or by a combination of
33 extraction and chemical synthesis and includes any packaging or
34 repackaging of the substance or labeling or relabeling of its container,
35 except that this term does not include the preparation or compounding of a
36 controlled substance by an individual for the individual's own lawful use
37 or the preparation, compounding, packaging or labeling of a controlled
38 substance:
39 (1) By a practitioner or the practitioner's agent pursuant to a lawful
40 order of a practitioner as an incident to the practitioner's administering or
41 dispensing of a controlled substance in the course of the practitioner's
42 professional practice; or
43 (2) by a practitioner or by the practitioner's authorized agent under
HB 2366 18
1 such practitioner's supervision for the purpose of or as an incident to
2 research, teaching or chemical analysis or by a pharmacist or medical care
3 facility as an incident to dispensing of a controlled substance.
4 (aa) "Marijuana" means all parts of all varieties of the plant Cannabis
5 whether growing or not, the seeds thereof, the resin extracted from any
6 part of the plant and every compound, manufacture, salt, derivative,
7 mixture or preparation of the plant, its seeds or resin. It does not include:
8 (1) The mature stalks of the plant, fiber produced from the stalks, oil
9 or cake made from the seeds of the plant, any other compound,
10 manufacture, salt, derivative, mixture or preparation of the mature stalks,
11 except the resin extracted therefrom, fiber, oil or cake or the sterilized seed
12 of the plant that is incapable of germination;
13 (2) any substance listed in schedules II through V of the uniform
14 controlled substances act;
15 (3) drug products approved by the United States food and drug
16 administration as of the effective date of this act;
17 (4) cannabidiol (other trade name: 2-[(3-methyl-6-(1-methylethenyl)-
18 2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol); or
19 (5) industrial hemp as defined in K.S.A. 2-3901, and amendments
20 thereto, when cultivated, produced, possessed or used for activities
21 authorized by the commercial industrial hemp act.
22 (bb) "Medical care facility" shall have the meaning ascribed to that
23 term means the same as defined in K.S.A. 65-425, and amendments
24 thereto.
25 (cc) "Mid-level practitioner" means a certified nurse-midwife
26 engaging in the independent practice of midwifery under the independent
27 practice of midwifery act, an advanced practice registered nurse issued a
28 license pursuant to K.S.A. 65-1131, and amendments thereto, who has
29 authority to prescribe drugs pursuant to a written protocol with a
30 responsible physician under K.S.A. 65-1130, and amendments thereto, or a
31 physician assistant licensed under the physician assistant licensure act who
32 has authority to prescribe drugs pursuant to a written agreement with a
33 supervising physician under K.S.A. 65-28a08, and amendments thereto.
34 (dd) "Narcotic drug" means any of the following whether produced
35 directly or indirectly by extraction from substances of vegetable origin or
36 independently by means of chemical synthesis or by a combination of
37 extraction and chemical synthesis:
38 (1) Opium and opiate and any salt, compound, derivative or
39 preparation of opium or opiate;
40 (2) any salt, compound, isomer, derivative or preparation thereof that
41 is chemically equivalent or identical with any of the substances referred to
42 in paragraph (1) but not including the isoquinoline alkaloids of opium;
43 (3) opium poppy and poppy straw; or
HB 2366 19
1 (4) coca leaves and any salt, compound, derivative or preparation of
2 coca leaves, and any salt, compound, isomer, derivative or preparation
3 thereof that is chemically equivalent or identical with any of these
4 substances, but not including decocainized coca leaves or extractions of
5 coca leaves that do not contain cocaine or ecgonine.
6 (ee) "Opiate" means any substance having an addiction-forming or
7 addiction-sustaining liability similar to morphine or being capable of
8 conversion into a drug having addiction-forming or addiction-sustaining
9 liability. It does not include, unless specifically designated as controlled
10 under K.S.A. 65-4102, and amendments thereto, the dextrorotatory isomer
11 of 3-methoxy-n-methylmorphinan and its salts (dextromethorphan). It does
12 include its racemic and levorotatory forms.
13 (ff) "Opium poppy" means the plant of the species Papaver
14 somniferum l. except its seeds.
15 (gg) "Person" means an individual, corporation, government, or
16 governmental subdivision or agency, business trust, estate, trust,
17 partnership or association or any other legal entity.
18 (hh) "Pharmacist" means any natural person licensed under K.S.A.
19 65-1625 et seq., and amendments thereto, to practice pharmacy.
20 (ii) "Pharmacist intern" means: (1) A student currently enrolled in an
21 accredited pharmacy program; (2) a graduate of an accredited pharmacy
22 program serving such person's internship; or (3) a graduate of a pharmacy
23 program located outside of the United States that is not accredited and who
24 had successfully passed equivalency examinations approved by the board.
25 (jj) "Pharmacy prescription application" means software that is used
26 to process prescription information, is installed on a pharmacy's computers
27 and servers, and is controlled by the pharmacy.
28 (kk) "Poppy straw" means all parts, except the seeds, of the opium
29 poppy, after mowing.
30 (ll) "Practitioner" means a person licensed to practice medicine and
31 surgery, dentist, podiatrist, veterinarian, optometrist, naturopathic doctor
32 or scientific investigator or other person authorized by law to use a
33 controlled substance in teaching or chemical analysis or to conduct
34 research with respect to a controlled substance.
35 (mm) "Prescriber" means a practitioner or a mid-level practitioner.
36 (nn) "Production" includes the manufacture, planting, cultivation,
37 growing or harvesting of a controlled substance.
38 (oo) "Readily retrievable" means that records kept by automatic data
39 processing applications or other electronic or mechanized recordkeeping
40 systems can be separated out from all other records within a reasonable
41 time not to exceed 48 hours of a request from the board or other authorized
42 agent or that hard-copy records are kept on which certain items are
43 asterisked, redlined or in some other manner visually identifiable apart
HB 2366 20
1 from other items appearing on the records.
2 (pp) "Ultimate user" means a person who lawfully possesses a
3 controlled substance for such person's own use or for the use of a member
4 of such person's household or for administering to an animal owned by
5 such person or by a member of such person's household.
6 Sec. 8. K.S.A. 65-7201 is hereby amended to read as follows: 65-
7 7201. K.S.A. 65-7201 to through 65-7218, inclusive and amendments
8 thereto, and sections 1 through 5, and amendments thereto, shall be known
9 and may be cited as the naturopathic doctor licensure act.
10 Sec. 9. K.S.A. 2022 Supp. 65-7202 is hereby amended to read as
11 follows: 65-7202. As used in K.S.A. 65-7201 through 65-7218, and
12 amendments thereto the naturopathic doctor licensure act:
13 (a) "Naturopathic doctor" means a doctor of naturopathic medicine
14 who is authorized and licensed pursuant to this act.
15 (b) (1) "Naturopathic medicine," or "naturopathy" means a system of
16 health care practiced by naturopathic doctors for the prevention, diagnosis
17 and treatment of human health conditions, injuries and diseases, that uses
18 education, natural medicines and therapies to support and stimulate the
19 individual's intrinsic self-healing processes, and includes: (A) Prescribing,
20 recommending or administering: (i) Food, food extracts, vitamins,
21 minerals, enzymes, whole gland thyroid, botanicals, homeopathic
22 preparations, nonprescription drugs, plant substances that are not
23 designated as prescription drugs or controlled substances, topical drugs as
24 defined in subsection (i); (ii) health care counseling, nutritional counseling
25 and dietary therapy, naturopathic physical applications, barrier
26 contraceptive devices; (iii) substances on the naturopathic formulary that
27 are authorized for intramuscular or intravenous administration pursuant to
28 a written protocol entered into with a physician who has entered into a
29 written protocol with a naturopathic doctor licensed under the naturopathic
30 doctor licensure act; (iv) noninvasive physical examinations, venipuncture
31 to obtain blood for clinical laboratory tests and orofacial examinations,
32 excluding endoscopies; (v) minor office procedures; and (vi) naturopathic
33 acupuncture; and (B) ordering diagnostic imaging studies, including, but
34 not limited to, x-ray, ultrasound, mammogram, bone densitometry,
35 computed tomography, magnetic resonance imaging and
36 electrocardiograms, except that naturopathic doctors shall refer patients to
37 an appropriately licensed and qualified healthcare professional to conduct
38 diagnostic imaging studies and interpret the results of such studies.
39 (2) A naturopathic doctor may not perform surgery, obstetrics,
40 administer ionizing radiation, or prescribe, dispense or administer any
41 controlled substances as defined in K.S.A. 65-4101, and amendments
42 thereto, or any prescription-only drugs except those listed on the
43 naturopathic formulary adopted by the board pursuant to this act.
HB 2366 21
1 (c) "Board" means the state board of healing arts.
2 (d) "Approved naturopathic medical college" means a college and
3 program granting the degree of doctor of naturopathy or naturopathic
4 medicine that has been approved by the board under this act and which
5 college and program requires at a minimum a graduate-level, four-year,
6 full-time resident program of academic and clinical study.
7 (e) "Homeopathic preparations" means substances and drugs prepared
8 according to the official homeopathic pharmacopoeia recognized by the
9 United States food and drug administration.
10 (f) "Naturopathic acupuncture" means the insertion of fine metal
11 needles through the skin at specific points on or near the surface of the
12 body with or without the palpation of specific points on the body and with
13 or without the application of electric current or heat to the needles or skin
14 or both to treat human disease and impairment and to relieve pain.
15 (g) "Minor office procedures" means care incidental to and treatment
16 of superficial tissue, superficial lacerations and, abrasions, superficial and
17 lesions and, the removal of foreign bodies located in the superficial tissues,
18 except eyes, and not involving blood vessels, tendons, ligaments or nerves
19 not involving the eyes, nerves, veins or arteries extending beyond
20 superficial tissue. "Minor office procedures" includes use of antiseptics,
21 but shall not include the topical anesthesia and local anesthesia, but does
22 not include the suturing, repairing, alteration or removal of tissue or the
23 use of general or spinal anesthesia. Minor office procedures does not
24 include anesthetics or surgery.
25 (h) "Naturopathic physical applications" means the therapeutic use by
26 naturopathic doctors of the actions or devices of electrical muscle
27 stimulation, galvanic, diathermy, electromagnetic energy, ultrasound,
28 ultraviolet light, constitutional heat, air, hot or cold hydrotherapy,
29 naturopathic musculoskeletal technique and, therapeutic exercise and
30 treatments taught in any approved medical college that are not otherwise
31 prohibited by this act.
32 (i) "Topical drugs" means topical analgesics, antiseptics, scabicides,
33 antifungals and antibacterials but does not include prescription only drugs.
34 (j) "Physician" means a person licensed to practice medicine and
35 surgery.
36 (k) "Written protocol" means a formal written agreement between a
37 naturopathic doctor licensed under this act and a person licensed to
38 practice medicine and surgery. Any licensee of the board entering into a
39 written protocol with a licensed naturopathic doctor shall notify the board
40 in writing of such relationship by providing such information as the board
41 may require.
42 Sec. 10. K.S.A. 65-7207 is hereby amended to read as follows: 65-
43 7207. (a) The board shall charge and collect in advance fees provided for
HB 2366 22
1 in this act as fixed by the board by rules and regulations, subject to the
2 following limitations:
3 Application fee, not more than.............................................................. $200
4 Temporary license fee, not more than..................................................... $30
5 License renewal fee, not more than....................................................... $150
6 License late renewal additional fee, not more than............................... $250
7 License reinstatement fee, not more than.............................................. $250
8 Certified copy of license, not more than................................................. $30
9 Written verification of license, not more than......................................... $25
10 (b) The board shall charge and collect in advance fees for any
11 examination administered by the board under the naturopathic doctor
12 licensure act as fixed by the board by rules and regulations in an amount
13 equal to the cost to the board of the examination. If the examination is not
14 administered by the board, the board may require that fees paid for any
15 examination under the naturopathic doctor licensure act be paid directly to
16 the examination service by the person taking the examination.
17 Sec. 11. K.S.A. 65-7208 is hereby amended to read as follows: 65-
18 7208. (a) The board may deny, refuse to renew, suspend, revoke, place
19 under probationary conditions or limit a licensee's license or the licensee
20 may be publicly or privately censured where the licensee or applicant for
21 licensure has been guilty of unprofessional conduct which has endangered
22 or is likely to endanger the health, welfare or safety of the public.
23 Unprofessional conduct includes upon a finding that a licensee has:
24 (1) Obtaining Obtained a license by means of fraud,
25 misrepresentation or concealment of material facts;
26 (2) being guilty committed an act of unprofessional conduct as
27 defined by rules and regulations adopted by the board;
28 (3) being been convicted of a felony if the acts for which such
29 person was convicted are found by the board to have a direct bearing on
30 whether such person should be entrusted to serve the public in the capacity
31 of a naturopathic doctor;
32 (4) violating violated any lawful order or rule and regulation of the
33 board; and
34 (5) violating violated any provision of this the naturopathic doctor
35 licensure act;
36 (6) an adverse judgment, award or settlement rendered against the
37 licensee resulting from a professional liability claim related to acts or
38 conduct similar to acts or conduct that would constitute grounds for
39 disciplinary action under this section;
40 (7) failed to report to the board any adverse action taken against the
41 licensee by another state or licensing jurisdiction, a healthcare facility, a
42 professional association or society, a governmental agency, a law
43 enforcement agency or a court for acts or conduct similar to acts or
HB 2366 23
1 conduct that would constitute grounds for disciplinary action under this
2 section;
3 (8) prescribed or administered a prescription drug or substance,
4 including a controlled substance, in an improper or inappropriate manner,
5 or for other than a valid medical purpose, or not in the course of the
6 licensee's professional practice; and
7 (9) given a worthless check or stopped payment on a debit or credit
8 card for fees or moneys legally due to the board.
9 (b) Such denial, refusal to renew, suspension, revocation, probation
10 or limitation of a license or public or private censure of a licensee may be
11 ordered by the board after notice and hearing on the matter in accordance
12 with the provisions of the Kansas administrative procedure act. Upon the
13 end of the period of time established by the board for the revocation of a
14 license, application may be made to the board for reinstatement. The board
15 shall have discretion to accept or reject an application for reinstatement
16 and may hold a hearing to consider such reinstatement. An application for
17 reinstatement of a revoked license shall be accompanied by the license
18 renewal fee and the license reinstatement fee established under K.S.A. 65-
19 7207, and amendments thereto.
20 (c) The board, in addition to any other penalty prescribed in
21 subsection (a), may assess a civil fine, after proper notice and an
22 opportunity to be heard, against a licensee for unprofessional conduct in an
23 amount not to exceed $5,000 for the first violation, $10,000 for the second
24 violation and $15,000 for the third violation and for each subsequent
25 violation. All fines assessed and collected under this section shall be
26 remitted to the state treasurer in accordance with the provisions of K.S.A.
27 75-4215, and amendments thereto. Upon receipt of each such remittance,
28 the state treasurer shall deposit the entire amount in the state treasury to
29 the credit of the state general fund. Fines collected under this section shall
30 be considered administrative fines pursuant to 11 U.S.C. § 523.
31 Sec. 12. K.S.A. 65-7209 is hereby amended to read as follows: 65-
32 7209. (a) Licenses issued under this act shall expire on the date of
33 expiration established by rules and regulations of the board be canceled on
34 January 31 of each year unless renewed in the manner prescribed by the
35 board. The request for renewal shall be accompanied by the license
36 renewal fee established pursuant to K.S.A. 65-7207, and amendments
37 thereto. The board may establish additional requirements for license
38 renewal which that provide evidence of continued competency. The board
39 shall require as a condition for renewal of a license completion of at least
40 25 hours annually of continuing education approved by the board.
41 (b) At least 30 days before the expiration renewal date of a licensee's
42 license, the board shall notify the licensee of the expiration renewal date
43 by mail addressed to the licensee's last mailing address as noted upon the
HB 2366 24
1 office records. If the licensee fails to submit the renewal application and
2 pay the renewal fee by the date of expiration renewal date, the licensee
3 shall be given a second notice that the license has expired and the license
4 may be renewed only if the license licensee has failed to submit the
5 renewal application and pay the renewal fee by the renewal date of the
6 license and that the license will be canceled if not renewed within 30 days
7 following the renewal date. The notice shall also state that if the renewal
8 application, the renewal fee and the an additional late renewal fee
9 established by rules and regulations are received by the board within the
10 thirty-day 30-day period following the date of expiration cancellation, the
11 license will not be canceled and that, if both fees are not received within
12 the thirty-day 30-day period, the license shall be deemed canceled by
13 operation of law without further proceedings for failure to renew and shall
14 be reissued only after the license has been reinstated under subsection (c).
15 (c) Any license canceled for failure to renew as herein provided in
16 this section may be reinstated upon recommendation of the board and
17 upon, payment of the license reinstatement fee and upon submitting
18 evidence of satisfactory completion of any applicable continuing education
19 requirements established by the board. The board shall adopt rules and
20 regulations establishing appropriate continuing education requirements for
21 reinstatement of licenses canceled for failure to renew.
22 (d) A person whose license is suspended shall not engage in any
23 conduct or activity in violation of the order or judgment by which the
24 license was suspended.
25 Sec. 13. K.S.A. 65-7214 is hereby amended to read as follows: 65-
26 7214. (a) There is established a naturopathic advisory council to advise the
27 board in carrying out the provisions of this act. The council shall consist of
28 five members, all citizens and residents of the state of Kansas appointed as
29 follows: Three members shall be naturopathic doctors appointed by the
30 state board of healing arts; one member shall be the president of the state
31 board of healing arts or a person designated by the president; and one
32 member appointed by the governor shall be from the public sector who is
33 not engaged, directly or indirectly, in the provision of health services.
34 Insofar as possible persons appointed to the council shall be from different
35 geographic areas. If a vacancy occurs on the council, the appointing
36 authority of the position which that has become vacant shall appoint a
37 person of like qualifications to fill the vacant position for the unexpired
38 term, if any. The members of the council appointed by the governor shall
39 be appointed for terms of three years and until a successor is appointed.
40 The members appointed by the state board of healing arts shall serve at the
41 pleasure of the state board of healing arts. If a member is designated by the
42 president of the state board of healing arts, the member shall serve at the
43 pleasure of the president.
HB 2366 25
1 (b) Members of the council attending meetings of the council, or
2 attending a subcommittee meeting thereof authorized by the council, shall
3 be paid amounts provided in subsection (e) of K.S.A. 75-3223(e), and
4 amendments thereto, from the healing arts fee fund.
5 (c) During the 2003 regular session of the legislature the legislature
6 shall consider establishing an alternative health care board composed of
7 representatives as may be designated from existing health care regulatory
8 agencies, alternative health care providers and members of the general
9 public for purposes of advising the legislature on matters relating to
10 alternative health care, administering the naturopathic doctor registration
11 act and performing such other duties as may be established by law.
12 (d) The provisions of this section shall take effect on and after
13 January 1, 2003.
14 Sec. 14. K.S.A. 65-7201, 65-7207, 65-7208, 65-7209 and 65-7214
15 and K.S.A. 2024 Supp. 65-1626, 65-4101 and 65-7202 and K.S.A. 2024
16 Supp. are hereby repealed.
17 Sec. 15. This act shall take effect and be in force from and after its
18 publication in the statute book.
[DELETED: An; le ad rn of nc dbK2sBN0(1eg e, ad ly es fr d2p3t4(5r6m7d8h9t0(1n2t3s4bs t t s ; 5n6nc pl a, br ce ds a7ie i; () ss ad fr i8s, i, i, l, t9pr or ir a, ig p0t1m2(3d4a5(]
[DELETED: 6((aii((((m l, dy or ay pe ig t0r1(2(3(4s5(6o7p8(9(0a1N213(4e5i6d7(e oy wn te nc dr hs a8e9a0(1o2N3f4(5s6u7(s ld to ee in te pe of n8m9i0s1(2a3t]
[DELETED: 6t(lpNeDif0p1(2m3s4N5o6i7e8p9s0S1f2(3a4(5i6o7(8(9o0(1t2(3t4p5c6wn ag in te ul ad ll ce of te cs o7w8(9s0(1a2d3(]
[DELETED: 6((2(1(dsp0d1(2d3(d p" ms a pn or p4mr tt hs ed io an at wh a5p6in a bs a or on rd to te me o7d8(9d0d1(2c3(s t f s r 4i5c6i7a8(9a0(1an of r p d os bd o r2r3(4a5(6r7m8w9(0e1(" or "" ms te a, ce o2a3a]
[DELETED: 6(ci(S((i(0h1(2c3(4a5(6p7p8as ae p, pe pl a, dn a9a0f1(" or "" ms to dr p2m3l4p, i, bt nt ld t, dg p5m6t7(8(9d0o1t2(3u4d5(6s7o8d9i0a1(2d3(]
[DELETED: 6l(ee d, of te ms pn dg to awptdo(0(1s2f3(4p5(6t7(8p9ps or a, et tt te tm "" ds nt i0a1b2o3(4(5c6c7(8(9i0(1(2m3i4c5( ie ds ad ml ss or or s6e7b8(c p" ms an ey p9p0p1(2t3p]
[DELETED: 6b(ktt is a pr pn as te se of te maa(c t" ms te tn of aec s n c a , m p0w1(2i3(4d5d6w7(8s9(e t" or "x t" ms t0t1p2i3p4a5p6p7p8p9(0n1(2m3i4() (l dg r" ms ay ln w5p6a7p8(9(0f1(2c3(]
[DELETED: 6(((((pa(t0ps wh re pt ey ad by o1iy e" as mg te ss f2"3J4(5b6ur cn op or cl of a ce e, or a7t8(9u0(1t2o3d4(t s s 5o6o7r8(9K0(142p3a4(5c6i7b8e9r0t1by an il fr te is on ue or te p2c3(]
[DELETED: 6pp(pt(dd(0(1t233n4m5(6o7o8(9r0(1(2o3t4l5a6(l p" ms a cd n7e8p9l0a1t2l3a4a5(6K7(g f" ms a fy at oe g8l9h0U1(" ms i, c, g2g3l]
[DELETED: 61(p(trs of ts se pg to te pe of pmcbe0N1t2(3(4a5(a ge of an ad py pm sg a6i7(8S9e0(" "" or "" ms p1l2(e ds ae od fr se we te pn o3p4d5(6"l c" "" "" "7"8o9c0p1(2p3o4r5c6b7(8u9p0m1p2a3s]
[DELETED: 61(dmppn(so0p1r2(3to y' ee as a pt ad wo ss ad i4r5e6(7(8o9o0c1d2(3c4o5(6u7Ut a 8p9o0(1l2p3p4t5a6i7(8d930(1(e or me is ig fe to ae to t2a3g]
[DELETED: 61(sn(a(kefm al or rs q ad e dg an in o0i1w2(3o4(5t6(7ds tt ae p, f pd b te mr o8d9r0n1py d; or () a dg id fr hn ue b2h3(4et tt ds of or oe ps se o5n6t7s8(9(0c1c2b3t4(5(6f7a8r9a0(a t ls pr fm wm a m1r2a3d]
[DELETED: 61(w(((c(o(0(1o2(3a4(5(6p7(n of ay at of sl a, mt o8e9(0n1(2s3s4r5t6y7(8f9l0s1bs of an id qe or cn wt a2a3(4l5c6d7(8m9(s te nw dg an or ad nw d0a1(2p3(]
[DELETED: 61p(a((tp(e d" ms ay pn ed iw0t1(2d3w4i5(6(7o8e9a0n1m2(3(4o5c6(7d8o9o0(1e2o3(4rs l 5o6a7S8f9(" ms te dt an of a c0s1t2(3o]
[DELETED: 61(o(taw(n se p" ms an ey tt ses0t1(2(3U4(5p667(8i9(0t1s2t3(4o5d6c748(9o0e1d2c344(5(6(7o8(9i0f1r2(3c]
[DELETED: 61tlp(m(e(" or "" ms te a, ce oa0w1(2u3i4s5p6(7a8i9(0d1(2(3(s 4p5o6(s 7t8(9a0(s 1s2(3a4(5f6c7ie cl i u or l to be u in t8m9p0(c p" ms an ey p1p2p3(]
[DELETED: 61tpb(ktt is a pr pn as te se of te maa(0p1e2d3(4g5(e t" or "x t" ms t6t7p8i9p0a1p2p3p4p5(6ts an ec pn bn te pr ad t7p8(9(0c1d2i3en ad cl ss ad is ay pg o4r5e6c7o8s9(0o1d2p3(]
[DELETED: 61srf(wpm(or ce me fm te ss of te p, ay or c0m1e2o3(4c5(6a7(829(0t wn c, p, pd or ud fr a1a2(3t m i4t5(l p" ms a cd n6e7p8l9a to pe d pt to a wn pl wh a0r1p2h3s4(5d6i7e8(m ad oe ad ay s, c, de o9p0(1i2i3(]
[DELETED: 61(ctsc(acl0u1o2i3(m p" ms te pt of te ss P4s5(" ms an i, c, g, o6gl sn or a, bs t, e, t7p8(960(1a2p3p4h5(6t7a8(9p0(1s2o3c4r5(6(7g8(9p0s1t2a3a]
[DELETED: 62f(s s cosS7 t t 6 i ata0S. 1f.  K2a3(4w5(6h7a8e9i0rg or a: () F, fd e, v1m, e, we gd t, b, h2p, nn d, pt ss tt ae n3d4d5ad dy t, nc pl a, b6c7a8a9w0d1t2e3a4nt ld t, x, u, m, be d5cd t, mc e ig a6e7a8d9( nc dr my nt pm s, o0a1c2t, or ay py ds et te ld on t3n]
[DELETED: 62((pmcf(aU0(1n2b3o4o5(6o7l8e9nt ig te e, n, vs or as eg b0s1b2n3u M4i5(6nc ds of te as or ds of el m7s, g, d ec e u8u l c h, a, ht or c h9n a t a0t1p2(3a4(5s6(7n8p9w0i1m2S37]
[DELETED: 62ifATLLLCW0(1e2l3e4a5e6t7S879u0m1l2o3U4( a le by ms of f5m6( o7d8( c i9p0w1o2(3b4(5l6(7l8c9d0(1l2pl an or s, a gl a, a l3e]
[DELETED: 62cs(iol(c(0o1o2w3e4l5s6a7r8r970(e b, in an to ay or py pd i1ss l 2o3a4v5v6r778t9t0b1S27.  e3e4J5b6r7t8r9s021(2l3b]
[DELETED: 62opsm lrlfae  t a le0t1l2t t 3 p3o4b5(6t m a7u pd n 8e9r0r1r2(3c4l5S677b8f9f0s1b2m3n4I5ga 6a7p8t9b0T1p2p3p]
[DELETED: 62(abn f  aa(srap0a1a2(3J4S5a6S7S8p]


================================================================================

Raw Text:
Session of 2025
HOUSE BILL No. 2366
By Committee on Health and Human Services
Requested by Kevin Barone, Kansas Naturopathic Doctors Association
2-7
1 AN ACT concerning health and healthcare; relating to the practice of
2 naturopathy; licensure and regulation of naturopathic doctors;
3 broadening the scope of practice of naturopathic doctors; amending
4 K.S.A. 65-7201, 65-7207, 65-7208, 65-7209 and 65-7214 and K.S.A.
5 2022 Supp. 65-1626, 65-4101 and 65-7202 and repealing the existing
6 sections.
7
8 Be it enacted by the Legislature of the State of Kansas:
9 New Section 1. (a) A naturopathic doctor may:
10 (1) Order and perform physical examinations, orifical examinations,
11 excluding endoscopies, and laboratory examinations for diagnostic
12 purposes, including, but not limited to, phlebotomy, clinical laboratory
13 tests, speculum examinations and physiological function tests;
14 (2) order diagnostic imaging studies, including, but not limited to, x-
15 ray, ultrasound, mammogram, bone densitometry, computed tomography,
16 magnetic resonance imaging and electrocardiograms, but a naturopathic
17 doctor shall refer patients to an appropriately licensed and qualified
18 healthcare professional to conduct diagnostic imaging studies and interpret
19 the results;
20 (3) prescribe, recommend or administer: (A) Food, food extracts,
21 nutraceuticals, vitamins, minerals, amino acids, enzymes, whole gland
22 thyroid, botanicals, homeopathic preparations, plant substances, dietary
23 supplements and nonprescription drugs; (B) human cellular and tissue-
24 based products that are not regulated as drugs; (C) healthcare and
25 nutritional counseling, including fertility counseling; (D) dietary therapy,
26 naturopathic physical applications, barrier contraceptive devices and
27 intrauterine insemination; (E) substances authorized for intradermal,
28 subcutaneous, intramuscular, intravenous, ligamentous, tendinous,
29 periarticular or intra-articular administration, including proliferative
30 therapy; (F) biofeedback and neurofeedback therapies; and (G) durable
31 medical equipment and devices;
32 (4) prescribe, administer or dispense: (A) Prescription-only drugs as
33 defined in K.S.A. 65-1626, and amendments thereto; and (B) testosterone,
34 as designated in K.S.A. 65-4109(f)(62), and amendments thereto;
35 (5) perform minor office procedures and naturopathic acupuncture;

HB 2366 2
1 (6) provide naturopathic care to a pregnant patient;
2 (7) utilize routes of administration that include oral, nasal, topical,
3 auricular, ocular, rectal, vaginal, transdermal, intradermal, subcutaneous,
4 intramuscular, ligamentous, tendinous, periarticular, intra-articular and
5 intravenous; and
6 (8) utilize non-diagnostic ultrasound in the performance of services.
7 (b) A naturopathic doctor shall not:
8 (1) Perform surgery;
9 (2) perform labor, delivery or any procedure involving the
10 reproductive organs of a pregnant patient;
11 (3) administer ionizing radiation for therapeutic purposes;
12 (4) use general or spinal anesthetics;
13 (5) administer, conduct or interpret the results of diagnostic imaging
14 studies except as authorized by this act;
15 (6) claim to practice any licensed healthcare profession or system
16 other than naturopathic medicine, unless holding a separate license in that
17 profession;
18 (7) perform procedures involving the termination of a pregnancy; or
19 (8) prescribe, administer or dispense any controlled substances not
20 authorized by this act.
21 New Sec. 2. A naturopathic doctor who prescribes pursuant to section
22 1(a)(3) and (a)(4), and amendments thereto, shall:
23 (a) Record each prescription order in writing, which may include an
24 electronically recorded and transmitted communication. The order shall
25 include the name, address and telephone number of the naturopathic
26 doctor;
27 (b) prescribe only when the naturopathic doctor has adequate
28 education, training and experience to safely manage the medical regimen;
29 and
30 (c) register with the United States drug enforcement administration in
31 order to prescribe controlled substances authorized by this act.
32 New Sec. 3. (a) The practice of naturopathy shall not include the
33 following:
34 (1) Persons whose professional services are performed under the
35 supervision or by order of or referral from a naturopathic doctor licensed
36 under the naturopathic doctor licensure act;
37 (2) persons licensed to engage in the practice of naturopathic
38 medicine in another state, territory or the District of Columbia when called
39 into this state in consultation with naturopathic doctors licensed in this
40 state; and
41 (3) practitioners of the healing arts licensed under the healing arts act
42 and practicing their professions or persons performing services pursuant to
43 the delegation of a licensee under K.S.A. 65-2872(g), and amendments

HB 2366 3
1 thereto.
2 (b) Nothing in this act shall be construed to restrict any person
3 licensed or regulated by the state of Kansas from engaging in the
4 profession or practice for which they are licensed or regulated.
5 New Sec. 4. (a) Every naturopathic doctor shall maintain a record for
6 each patient for whom a professional service is rendered, including:
7 Documentation of dates of professional services, pertinent and significant
8 information regarding the patient's condition, examinations and testing, all
9 findings and results, diagnosis and treatment performed or recommended,
10 patient progress and all patient records received from other providers.
11 (b) Every naturopathic doctor shall maintain a patient's record for a
12 minimum of 10 years from the date the licensee provided the professional
13 service recorded.
14 New Sec. 5. If any provision of the naturopathic doctor licensure act
15 or application thereof to any person or circumstance is held invalid, such
16 invalidity shall not affect other provisions or applications that can be given
17 effect without the invalid provision or application, and to this end, the
18 provisions of the naturopathic doctor licensure act are declared to be
19 severable.
20 Sec. 6. K.S.A. 2024 Supp. 65-1626 is hereby amended to read as
21 follows: 65-1626. As used in the pharmacy act of the state of Kansas:
22 (a) "Address" means, with respect to prescriptions, the physical
23 address where a patient resides, including street address, city and state.
24 (b) "Administer" means the direct application of a drug, whether by
25 injection, inhalation, ingestion or any other means, to the body of a patient
26 or research subject by:
27 (1) A practitioner or pursuant to the lawful direction of a practitioner;
28 (2) the patient or research subject at the direction and in the presence
29 of the practitioner; or
30 (3) a pharmacist as authorized in K.S.A. 65-1635a, and amendments
31 thereto, or K.S.A. 2024 Supp. 65-16,129, and amendments thereto.
32 (c) "Agent" means an authorized person who acts on behalf of or at
33 the direction of a manufacturer, repackager, wholesale distributor, third-
34 party logistics provider or dispenser but does not include a common
35 carrier, public warehouseman or employee of the carrier or warehouseman
36 when acting in the usual and lawful course of the carrier's or
37 warehouseman's business.
38 (d) "Automated dispensing system" means a robotic or mechanical
39 system controlled by a computer that:
40 (1) Performs operations or activities, other than compounding or
41 administration, relative to the storage, packaging, labeling, dispensing or
42 distribution of drugs;
43 (2) collects, controls and maintains all transaction information; and

HB 2366 4
1 (3) operates in accordance with the board's rules and regulations.
2 (e) "Biological product" means the same as defined in 42 U.S.C. §
3 262(i), as in effect on January 1, 2017.
4 (f) "Board" means the state board of pharmacy created by K.S.A. 74-
5 1603, and amendments thereto.
6 (g) "Brand exchange," in the case of a drug prescribed, means the
7 dispensing of a different drug product of the same dosage form and
8 strength and of the same generic name as the brand name drug product
9 prescribed, and in the case of a biological product prescribed, means the
10 dispensing of an interchangeable biological product.
11 (h) "Brand name" means the registered trademark name given to a
12 drug product by its manufacturer, labeler or distributor.
13 (i) "Co-licensed partner" means a person or pharmaceutical
14 manufacturer that has entered into an agreement with another
15 pharmaceutical manufacturer or an affiliate of the manufacturer to engage
16 in a business activity or occupation related to the manufacture or
17 distribution of a product.
18 (j) "Common carrier" means any person who undertakes, whether
19 directly or by any other arrangement, to transport property, including
20 drugs, for compensation.
21 (k) (1) "Compounding" means the combining of components into a
22 compounded preparation under either of the following conditions:
23 (A) As the result of a practitioner's prescription drug order or
24 initiative based on the practitioner-patient-pharmacist relationship in the
25 course of professional practice to meet the specialized medical need of an
26 individual patient of the practitioner that cannot be filled by an FDA-
27 approved drug; or
28 (B) for the purpose of, or incidental to, research, teaching or chemical
29 analysis, and not for sale or dispensing.
30 (2) Compounding includes the preparation of drugs or devices in
31 anticipation of receiving prescription drug orders based on routine,
32 regularly observed prescribing patterns.
33 (3) Compounding does not include reconstituting any mixed drug
34 according to the FDA-approved labeling for the drug.
35 (l) "Current good manufacturing practices" or "CGMP" means the
36 requirements for ensuring that drugs and drug products are consistently
37 manufactured, repackaged, produced, stored and dispensed in accordance
38 with 21 C.F.R. §§ 207, 210 and 211.
39 (m) "DEA" means the United States department of justice, drug
40 enforcement administration.
41 (n) "Deliver" or "delivery" means the actual, constructive or
42 attempted transfer from one person to another of any drug whether or not
43 an agency relationship exists.

HB 2366 5
1 (o) "Device" means an instrument, apparatus, implement, machine,
2 contrivance, implant, in vitro reagent or other similar or related article,
3 including a component part or accessory that:
4 (1) (A) Is recognized in the official national formulary, or the United
5 States pharmacopoeia, or any supplement thereof;
6 (B) is intended for use in the diagnosis of disease or other conditions;
7 (C) is used for the cure, mitigation, treatment or prevention of disease
8 in human or other animals; or
9 (D) is intended to affect the structure or any function of the body of
10 human or other animals; and
11 (2) (A) does not achieve its primary intended purposes through
12 chemical action within or on the body of human or other animals; and
13 (B) is not dependent upon being metabolized for the achievement of
14 any of its primary intended purposes.
15 (p) "Direct supervision" means the process by which the responsible
16 pharmacist shall observe and direct the activities of a pharmacist intern or
17 pharmacy technician, be readily and immediately available at all time
18 activities are performed, provide personal assistance, direction and
19 approval throughout the time the activities are performed and complete the
20 final check before dispensing.
21 (q) "Dispense" or "dispensing" means to deliver prescription
22 medication to the ultimate user or research subject by or pursuant to the
23 lawful order of a practitioner or pursuant to the prescription of a mid-level
24 practitioner, including, but not limited to, delivering prescription
25 medication to a patient by mail, common carrier, personal delivery or
26 third-party delivery to any location requested by the patient.
27 (r) "Dispenser" means:
28 (1) A practitioner or pharmacist who dispenses prescription drugs or
29 devices or a physician assistant who has authority to dispense prescription-
30 only drugs in accordance with K.S.A. 65-28a08(b), and amendments
31 thereto; or
32 (2) a retail pharmacy, hospital pharmacy or group of pharmacies
33 under common ownership and control that do not act as a wholesale
34 distributor.
35 (s) "Distribute" or "distribution" means to deliver, offer to deliver,
36 sell, offer to sell, purchase, trade, transfer, broker, give away, handle, store
37 or receive, other than by administering or dispensing, any product, but
38 does not include dispensing a product pursuant to a prescription executed
39 in accordance with 21 U.S.C. § 353 or the dispensing of a product
40 approved under 21 U.S.C. § 360b.
41 (t) "Distributor" means a person or entity that distributes a drug or
42 device.
43 (u) "Diversion" means the transfer of a controlled substance from a

HB 2366 6
1 lawful to an unlawful channel of distribution or use.
2 (v) "Drop shipment" means the sale, by a manufacturer, repackager or
3 exclusive distributor, of the manufacturer's prescription drug to a
4 wholesale distributor whereby the wholesale distributor takes title but not
5 possession of such prescription drug and the wholesale distributor invoices
6 the dispenser, and the dispenser receives delivery of the prescription drug
7 directly from the manufacturer, repackager, third-party logistics provider
8 or exclusive distributor, of such prescription drug.
9 (w) "Drug" means articles:
10 (1) Recognized in the official United States pharmacopeia, or other
11 such official compendiums of the United States, or official national
12 formulary, or any supplement to any of them;
13 (2) intended for use in the diagnosis, cure, mitigation, treatment or
14 prevention of disease in human or other animals;
15 (3) other than food, intended to affect the structure or any function of
16 the body of human or other animals; and
17 (4) intended for use as a component of any articles specified in
18 paragraph (1), (2) or (3); but does not include devices or their components,
19 parts or accessories, except that the term "drug" does not include
20 amygdalin (laetrile) or any livestock remedy, if such livestock remedy had
21 been registered in accordance with the provisions of article 5 of chapter 47
22 of the Kansas Statutes Annotated, prior to its repeal.
23 (x) "Durable medical equipment" means equipment that:
24 (1) Provides therapeutic benefits or enables an individual to perform
25 certain tasks that the individual is unable to otherwise undertake due to
26 certain medical conditions or illnesses;
27 (2) is primarily and customarily used to serve a medical purpose;
28 (3) generally is not useful to a person in the absence of an illness or
29 injury;
30 (4) can withstand repeated use;
31 (5) is appropriate for use in the home, long-term care facility or
32 medical care facility, but may be transported to other locations to allow the
33 individual to complete instrumental activities of daily living that are more
34 complex tasks required for independent living; and
35 (6) may include devices and medical supplies or other similar
36 equipment determined by the board in rules and regulations adopted by the
37 board.
38 (y) "Electronic prescription" means an electronically prepared
39 prescription that is authorized and transmitted from the prescriber to the
40 pharmacy by means of electronic transmission.
41 (z) "Electronic prescription application" means software that is used
42 to create electronic prescriptions and that is intended to be installed on the
43 prescriber's computers and servers where access and records are controlled

HB 2366 7
1 by the prescriber.
2 (aa) "Electronic signature" means a confidential personalized digital
3 key, code, number or other method for secure electronic data transmissions
4 that identifies a particular person as the source of the message,
5 authenticates the signatory of the message and indicates the person's
6 approval of the information contained in the transmission.
7 (bb) "Electronic transmission" means the transmission of an
8 electronic prescription, formatted as an electronic data file, from a
9 prescriber's electronic prescription application to a pharmacy's computer,
10 where the data file is imported into the pharmacy prescription application.
11 (cc) "Electronically prepared prescription" means a prescription that
12 is generated using an electronic prescription application.
13 (dd) "Exclusive distributor" means the wholesale distributor that
14 directly purchased the product from the manufacturer and is the sole
15 distributor of that manufacturer's product to a subsequent repackager,
16 wholesale distributor or dispenser.
17 (ee) "FDA" means the United States department of health and human
18 services, food and drug administration.
19 (ff) "Facsimile transmission" or "fax transmission" means the
20 transmission of a digital image of a prescription from the prescriber or the
21 prescriber's agent to the pharmacy. "Facsimile transmission" includes, but
22 is not limited to, transmission of a written prescription between the
23 prescriber's fax machine and the pharmacy's fax machine; transmission of
24 an electronically prepared prescription from the prescriber's electronic
25 prescription application to the pharmacy's fax machine, computer or
26 printer; or transmission of an electronically prepared prescription from the
27 prescriber's fax machine to the pharmacy's fax machine, computer or
28 printer.
29 (gg) "Generic name" means the established chemical name or official
30 name of a drug or drug product.
31 (hh) "Healthcare entity" means any person that provides diagnostic,
32 medical, surgical or dental treatment or rehabilitative care but does not
33 include any retail pharmacy or wholesale distributor.
34 (ii) (1) "Institutional drug room" means any location where
35 prescription-only drugs are stored and from which prescription-only drugs
36 are administered or dispensed and that is maintained or operated for the
37 purpose of providing the drug needs of:
38 (A) Inmates of a jail or correctional institution or facility;
39 (B) residents of a juvenile correctional facility or juvenile detention
40 facility, as defined in K.S.A. 38-2302, and amendments thereto;
41 (C) students of a public or private university or college, a community
42 college or any other institution of higher learning that is located in Kansas;
43 (D) employees of a business or other employer; or

HB 2366 8
1 (E) persons receiving inpatient hospice services.
2 (2) "Institutional drug room" does not include:
3 (A) Any registered pharmacy;
4 (B) any office of a practitioner; or
5 (C) a location where no prescription-only drugs are dispensed and no
6 prescription-only drugs other than individual prescriptions are stored or
7 administered.
8 (jj) "Interchangeable biological product" means a biological product
9 that the FDA has identified in the "purple book: lists of licensed biological
10 products with reference product exclusivity and biosimilarity or
11 interchangeability evaluations" as meeting the standards for
12 "interchangeability" as defined in 42 U.S.C. § 262(k), as in effect on
13 January 1, 2017.
14 (kk) "Intracompany transaction" means any transaction or transfer
15 between any division, subsidiary, parent or affiliated or related company
16 under common ownership or control of a corporate entity, or any
17 transaction or transfer between co-licensed partners.
18 (ll) "Label" means a display of written, printed or graphic matter
19 upon the immediate container of any drug.
20 (mm) "Labeling" means the process of preparing and affixing a label
21 to any drug container, exclusive of the labeling by a manufacturer, packer
22 or distributor of a non-prescription drug or commercially packaged legend
23 drug.
24 (nn) "Fingerprint candidate" means a person who has made an
25 original application for or reinstatement of any license, registration, permit
26 or certificate under this act or a person who currently holds a license,
27 registration, permit or certificate under this act.
28 (oo) "Long-term care facility" means "nursing facility," as defined in
29 K.S.A. 39-923, and amendments thereto.
30 (pp) "Medical care facility" means the same as defined in K.S.A. 65-
31 425, and amendments thereto, and also includes psychiatric hospitals and
32 psychiatric residential treatment facilities as defined by K.S.A. 39-2002,
33 and amendments thereto.
34 (qq) "Manufacture" means the production, preparation, propagation,
35 compounding, conversion or processing of a drug either directly or
36 indirectly by extraction from substances of natural origin, independently
37 by means of chemical or biological synthesis or by a combination of
38 extraction and chemical or biological synthesis or the packaging or
39 repackaging of the drug or labeling or relabeling of its container, except
40 that this term does not include the preparation or compounding of a drug
41 by an individual for the individual's own use or the preparation,
42 compounding, packaging or labeling of a drug by:
43 (1) A practitioner or a practitioner's authorized agent incident to such

HB 2366 9
1 practitioner's administering or dispensing of a drug in the course of the
2 practitioner's professional practice;
3 (2) a practitioner, by a practitioner's authorized agent or under a
4 practitioner's supervision for the purpose of, or as an incident to, research,
5 teaching or chemical analysis and not for sale; or
6 (3) a pharmacist or the pharmacist's authorized agent acting under the
7 direct supervision of the pharmacist for the purpose of, or incident to, the
8 dispensing of a drug by the pharmacist.
9 (rr) "Manufacturer" means:
10 (1) A person that holds an application approved under section 505 of
11 the federal food, drug and cosmetic act or a license issued under section
12 351 of the federal public health service act for such drug or, if such drug is
13 not the subject of an approved application or license, the person who
14 manufactured the drug;
15 (2) a co-licensed partner of the person described in paragraph (1) that
16 obtains the drug directly from a person described in paragraph (1) or (3);
17 or
18 (3) an affiliate of a person described in paragraph (1) or (2) that
19 receives the product directly from a person described in paragraph (1) or
20 (2).
21 (ss) "Medication order" means a written or oral order by a prescriber
22 or the prescriber's authorized agent for administration of a drug or device
23 to a patient in a Kansas licensed medical care facility or in a Kansas
24 licensed nursing facility or nursing facility for mental health, as such terms
25 are defined by K.S.A. 39-923, and amendments thereto.
26 (tt) "Mid-level practitioner" means a certified nurse-midwife
27 engaging in the independent practice of midwifery under the independent
28 practice of midwifery act, an advanced practice registered nurse issued a
29 license pursuant to K.S.A. 65-1131, and amendments thereto, who has
30 authority to prescribe drugs under K.S.A. 65-1130, and amendments
31 thereto, or a physician assistant licensed pursuant to the physician assistant
32 licensure act who has authority to prescribe drugs pursuant to a written
33 agreement with a supervising physician under K.S.A. 65-28a08, and
34 amendments thereto.
35 (uu) "Nonresident pharmacy" means a pharmacy located outside of
36 Kansas.
37 (vv) "Outsourcing facility" means a facility at one geographic
38 location or address that is engaged in the compounding of sterile drugs and
39 has registered with the FDA as an outsourcing facility pursuant to 21
40 U.S.C. § 353b.
41 (ww) "Person" means individual, corporation, government,
42 governmental subdivision or agency, partnership, association or any other
43 legal entity.

HB 2366 10
1 (xx) "Pharmacist" means any natural person licensed under this act to
2 practice pharmacy.
3 (yy) "Pharmacist-in-charge" means the pharmacist who is responsible
4 to the board for a registered establishment's compliance with the laws and
5 regulations of this state pertaining to the practice of pharmacy,
6 manufacturing of drugs and the distribution of drugs. The pharmacist-in-
7 charge shall supervise such establishment on a full-time or a part-time
8 basis and perform such other duties relating to supervision of a registered
9 establishment as may be prescribed by the board by rules and regulations.
10 Nothing in this definition shall relieve other pharmacists or persons from
11 their responsibility to comply with state and federal laws and regulations.
12 (zz) "Pharmacist intern" or "intern" means:
13 (1) A student currently enrolled in and in good standing with an
14 accredited pharmacy program;
15 (2) a graduate of an accredited pharmacy program serving an
16 internship; or
17 (3) a graduate of a pharmacy program located outside of the United
18 States that is not accredited and who has successfully passed equivalency
19 examinations approved by the board.
20 (aaa) "Pharmacy," "drugstore" or "apothecary" means premises,
21 laboratory, area or other place, including any electronic medium:
22 (1) Where drugs are offered for sale where the profession of
23 pharmacy is practiced and where prescriptions are compounded and
24 dispensed;
25 (2) that has displayed upon it or within it the words "pharmacist,"
26 "pharmaceutical chemist," "pharmacy," "apothecary," "drugstore,"
27 "druggist," "drugs," "drug sundries" or any of these words or combinations
28 of these words or words of similar import in any language or on any sign
29 containing any of these words as used in the context of health, medical or
30 pharmaceutical care or services; or
31 (3) where the characteristic symbols of pharmacy or the characteristic
32 prescription sign "Rx" may be exhibited in the context of health, medical
33 or pharmaceutical care or services. As used in this subsection, premises
34 refers only to the portion of any building or structure leased, used or
35 controlled by the licensee in the conduct of the business registered by the
36 board at the address for which the registration was issued.
37 (bbb) "Pharmacy prescription application" means software that is
38 used to process prescription information and is either installed on a
39 pharmacy's computers or servers and is controlled by the pharmacy or is
40 maintained on the servers of an entity that sells electronic pharmacy
41 prescription applications as a hosted service where the entity controls
42 access to the application and maintains the software and records on its
43 server.

HB 2366 11
1 (ccc) "Pharmacy technician" means an individual who, under the
2 direct supervision and control of a pharmacist, may perform packaging,
3 manipulative, repetitive or other nondiscretionary tasks related to the
4 processing of a prescription or medication order and who assists the
5 pharmacist in the performance of pharmacy-related duties, but who does
6 not perform duties restricted to a pharmacist.
7 (ddd) "Practitioner" means a person licensed to practice medicine and
8 surgery, dentist, podiatrist, veterinarian, optometrist, naturopathic doctor
9 or scientific investigator or other person authorized by law to use a
10 prescription-only drug in teaching or chemical analysis or to conduct
11 research with respect to a prescription-only drug.
12 (eee) "Preceptor" means a licensed pharmacist who possesses at least
13 two years' experience as a pharmacist and who supervises and is
14 responsible for the actions of pharmacist interns obtaining pharmaceutical
15 experience.
16 (fff) "Prescriber" means a practitioner or a mid-level practitioner.
17 (ggg) "Prescription" or "prescription order" means the front and back
18 of a lawful written, electronic or facsimile order from a prescriber or an
19 oral order from a prescriber or the prescriber's authorized agent that
20 communicates the prescriber's instructions for a prescription drug or
21 device to be dispensed.
22 (hhh) "Prescription medication" means any drug, including label and
23 container according to context, that is dispensed pursuant to a prescription
24 order.
25 (iii) "Prescription-only drug" means any drug whether intended for
26 use by human or animal, required by federal or state law, including 21
27 U.S.C. § 353, to be dispensed only pursuant to a written or oral
28 prescription or order of a practitioner or is restricted to use by practitioners
29 only.
30 (jjj) "Probation" means the practice or operation under a temporary
31 license, registration or permit or a conditional license, registration or
32 permit of a business or profession for which a license, registration or
33 permit is granted by the board under the provisions of the pharmacy act of
34 the state of Kansas requiring certain actions to be accomplished or certain
35 actions not to occur before a regular license, registration or permit is
36 issued.
37 (lll) "Product" means the same as defined by part H of the federal
38 drug supply chain security act, 21 U.S.C. § 351 et seq. and 21 U.S.C. §
39 360eee.
40 (mmm) "Professional incompetency" means:
41 (1) One or more instances involving failure to adhere to the
42 applicable standard of pharmaceutical care to a degree that constitutes
43 gross negligence, as determined by the board;

HB 2366 12
1 (2) repeated instances involving failure to adhere to the applicable
2 standard of pharmaceutical care to a degree that constitutes ordinary
3 negligence, as determined by the board; or
4 (3) a pattern of pharmacy practice or other behavior that demonstrates
5 a manifest incapacity or incompetence to practice pharmacy.
6 (nnn) "Readily retrievable" or "readily available" means that records
7 kept in hard copy or by automatic data processing applications or other
8 electronic or mechanized record-keeping systems can be separated out
9 from all other records quickly and easily during an inspection or
10 investigation, or within a reasonable time not to exceed 48 hours of a
11 written request from the board or other authorized agent.
12 (ooo) "Repackage" means changing the container, wrapper, quantity
13 or label of a drug to further the distribution of the drug.
14 (ppp) "Repackager" means a person who owns or operates a facility
15 that repackages.
16 (qqq) "Retail dealer" means a person selling at retail nonprescription
17 drugs that are prepackaged, fully prepared by the manufacturer or
18 distributor for use by the consumer and labeled in accordance with the
19 requirements of the state and federal food, drug and cosmetic acts. Such
20 nonprescription drugs shall not include: (1) A controlled substance; (2) a
21 prescription-only drug; or (3) a drug intended for human use by
22 hypodermic injection.
23 (rrr) "Reverse distributor" means a person who owns or operates an
24 establishment that disposes of or otherwise processes saleable or
25 nonsaleable products received from an authorized trading partner such that
26 the product may be processed for credit to the purchaser, manufacturer or
27 seller or disposed of for no further distribution.
28 (sss) "Secretary" means the executive secretary of the board.
29 (ttt) "Third-party logistics provider" means an entity that provides or
30 coordinates warehousing or other logistic services of a product in interstate
31 commerce on behalf of a manufacturer, wholesale distributor or dispenser,
32 but does not take ownership of the product or have responsibility to direct
33 the sale or disposition of the product.
34 (uuu) "Trading partner" means:
35 (1) A manufacturer, repackager, wholesale distributor or dispenser
36 from whom a manufacturer, repackager, wholesale distributor or dispenser
37 accepts direct ownership of a product or to whom a manufacturer,
38 repackager, wholesale distributor or dispenser transfers direct ownership of
39 a product; or
40 (2) a third-party logistics provider from whom a manufacturer,
41 repackager, wholesale distributor or dispenser accepts direct possession of
42 a product or to whom a manufacturer, repackager, wholesale distributor or
43 dispenser transfers direct possession of a product.

HB 2366 13
1 (vvv) "Transaction" means the transfer of product between persons in
2 which a change of ownership occurs.
3 (www) "Unprofessional conduct" means:
4 (1) Fraud in securing a registration or permit;
5 (2) intentional adulteration or mislabeling of any drug, medicine,
6 chemical or poison;
7 (3) causing any drug, medicine, chemical or poison to be adulterated
8 or mislabeled, knowing the same to be adulterated or mislabeled;
9 (4) intentionally falsifying or altering records or prescriptions;
10 (5) unlawful possession of drugs and unlawful diversion of drugs to
11 others;
12 (6) willful betrayal of confidential information under K.S.A. 65-1654,
13 and amendments thereto;
14 (7) conduct likely to deceive, defraud or harm the public;
15 (8) making a false or misleading statement regarding the licensee's
16 professional practice or the efficacy or value of a drug;
17 (9) commission of any act of sexual abuse, misconduct or
18 exploitation related to the licensee's professional practice; or
19 (10) performing unnecessary tests, examinations or services that have
20 no legitimate pharmaceutical purpose.
21 (xxx) "Vaccination protocol" means a written protocol, agreed to and
22 signed by a pharmacist and a person licensed to practice medicine and
23 surgery by the state board of healing arts, that establishes procedures and
24 recordkeeping and reporting requirements for administering a vaccine by
25 the pharmacist for a period of time specified therein, not to exceed two
26 years.
27 (yyy) "Valid prescription order" means a prescription that is issued
28 for a legitimate medical purpose by an individual prescriber licensed by
29 law to administer and prescribe drugs and acting in the usual course of
30 such prescriber's professional practice. A prescription issued solely on the
31 basis of an internet-based questionnaire or consultation without an
32 appropriate prescriber-patient relationship is not a valid prescription order.
33 (zzz) "Veterinary medical teaching hospital pharmacy" means any
34 location where prescription-only drugs are stored as part of an accredited
35 college of veterinary medicine and from which prescription-only drugs are
36 distributed for use in treatment of or administration to a nonhuman.
37 (aaaa) "Virtual manufacturer" means an entity that engages in the
38 manufacture of a drug or device for which it:
39 (1) Owns the new drug application or abbreviated new drug
40 application number, if a prescription drug;
41 (2) owns the unique device identification number, as available, for a
42 prescription device;
43 (3) contracts with a contract manufacturing organization for the

HB 2366 14
1 physical manufacture of the drug or device;
2 (4) is not involved in the physical manufacture of the drug or device;
3 and
4 (5) does not store or take physical possession of the drug or device.
5 (bbbb) "Virtual wholesale distributor" means a wholesale distributor
6 that sells, brokers or transfers a drug or device but never physically
7 possesses the product.
8 (cccc) "Wholesale distributor" means any person engaged in
9 wholesale distribution or reverse distribution of drugs or devices, other
10 than a manufacturer, co-licensed partner or third-party logistics provider.
11 (dddd) "Wholesale distribution" means the distribution or receipt of
12 drugs or devices to or by persons other than consumers or patients, in
13 which a change of ownership occurs. "Wholesale distribution" does not
14 include:
15 (1) The dispensing of a drug or device pursuant to a prescription;
16 (2) the distribution of a drug or device or an offer to distribute a drug
17 or device for emergency medical reasons, including a public health
18 emergency declaration pursuant to section 319 of the public health service
19 act, except that, for purposes of this paragraph, a drug or device shortage
20 not caused by a public health emergency shall not constitute an emergency
21 medical reason;
22 (3) intracompany distribution;
23 (4) the distribution of a drug or device, or an offer to distribute a drug
24 or device, among hospitals or other healthcare entities under common
25 control;
26 (5) the distribution of a drug or device, or the offer to distribute a
27 drug or device, by a charitable organization described in section 501(c)(3)
28 of the internal revenue code of 1986 to a nonprofit affiliate of the
29 organization to the extent otherwise permitted by law;
30 (6) the distribution of an intravenous drug used to maintain the
31 equilibrium of water and minerals in the body, such as dialysis solutions;
32 or
33 (7) the sale or transfer from a retail pharmacy of expired, damaged,
34 returned or recalled prescription drugs to the original manufacturer,
35 originating wholesale distributor or to a reverse distributor registered in
36 accordance with the board's rules and regulations.
37 Sec. 7. K.S.A. 2022 Supp. 65-4101 is hereby amended to read as
38 follows: 65-4101. As used in this act:
39 (a) "Administer" means the direct application of a controlled
40 substance, whether by injection, inhalation, ingestion or any other means,
41 to the body of a patient or research subject by:
42 (1) A practitioner or pursuant to the lawful direction of a practitioner;
43 or

HB 2366 15
1 (2) the patient or research subject at the direction and in the presence
2 of the practitioner.
3 (b) "Agent" means an authorized person who acts on behalf of or at
4 the direction of a manufacturer, distributor or dispenser. It does not include
5 a common carrier, public warehouseman or employee of the carrier or
6 warehouseman.
7 (c) "Application service provider" means an entity that sells
8 electronic prescription or pharmacy prescription applications as a hosted
9 service where the entity controls access to the application and maintains
10 the software and records on its server.
11 (d) "Board" means the state board of pharmacy.
12 (e) "Bureau" means the bureau of narcotics and dangerous drugs,
13 United States department of justice, or its successor agency.
14 (f) "Controlled substance" means any drug, substance or immediate
15 precursor included in any of the schedules designated in K.S.A. 65-4105,
16 65-4107, 65-4109, 65-4111 and 65-4113, and amendments thereto.
17 (g) (1) "Controlled substance analog" means a substance that is
18 intended for human consumption, and at least one of the following:
19 (A) The chemical structure of the substance is substantially similar to
20 the chemical structure of a controlled substance listed in or added to the
21 schedules designated in K.S.A. 65-4105 or 65-4107, and amendments
22 thereto;
23 (B) the substance has a stimulant, depressant or hallucinogenic effect
24 on the central nervous system substantially similar to the stimulant,
25 depressant or hallucinogenic effect on the central nervous system of a
26 controlled substance included in the schedules designated in K.S.A. 65-
27 4105 or 65-4107, and amendments thereto; or
28 (C) with respect to a particular individual, such individual represents
29 or intends the substance to have a stimulant, depressant or hallucinogenic
30 effect on the central nervous system substantially similar to the stimulant,
31 depressant or hallucinogenic effect on the central nervous system of a
32 controlled substance included in the schedules designated in K.S.A. 65-
33 4105 or 65-4107, and amendments thereto.
34 (2) "Controlled substance analog" does not include:
35 (A) A controlled substance;
36 (B) a substance for which there is an approved new drug application;
37 or
38 (C) a substance with respect to which an exemption is in effect for
39 investigational use by a particular person under section 505 of the federal
40 food, drug and cosmetic act, 21 U.S.C. § 355, to the extent conduct with
41 respect to the substance is permitted by the exemption.
42 (h) "Counterfeit substance" means a controlled substance that, or the
43 container or labeling of which, without authorization bears the trademark,

HB 2366 16
1 trade name or other identifying mark, imprint, number or device or any
2 likeness thereof of a manufacturer, distributor or dispenser other than the
3 person who in fact manufactured, distributed or dispensed the substance.
4 (i) "Cultivate" means the planting or promotion of growth of five or
5 more plants that contain or can produce controlled substances.
6 (j) "DEA" means the U.S. United States department of justice, drug
7 enforcement administration.
8 (k) "Deliver" or "delivery" means the actual, constructive or
9 attempted transfer from one person to another of a controlled substance,
10 whether or not there is an agency relationship.
11 (l) "Dispense" means to deliver a controlled substance to an ultimate
12 user or research subject by or pursuant to the lawful order of a practitioner,
13 including the packaging, labeling or compounding necessary to prepare the
14 substance for that delivery, or pursuant to the prescription of a mid-level
15 practitioner.
16 (m) "Dispenser" means a practitioner or pharmacist who dispenses, or
17 a physician assistant who has authority to dispense prescription-only drugs
18 in accordance with K.S.A. 65-28a08(b), and amendments thereto.
19 (n) "Distribute" means to deliver other than by administering or
20 dispensing a controlled substance.
21 (o) "Distributor" means a person who distributes.
22 (p) (1) "Drug" means substances:
23 (A) Substances Recognized as drugs in the official United States
24 pharmacopeia, official homeopathic pharmacopoeia of the United States or
25 official national formulary or any supplement to any of them;
26 (B) substances intended for use in the diagnosis, cure, mitigation,
27 treatment or prevention of disease in human or animals;
28 (C) substances (other than food) intended to affect the structure or
29 any function of the body of human or animals; and
30 (D) substances intended for use as a component of any article
31 specified in subparagraph (A), (B) or (C).
32 (2) "Drug" does not include devices or their components, parts or
33 accessories.
34 (q) "Immediate precursor" means a substance that the board has
35 found to be and by rule and regulation designates as being the principal
36 compound commonly used or produced primarily for use and that is an
37 immediate chemical intermediary used or likely to be used in the
38 manufacture of a controlled substance, the control of which is necessary to
39 prevent, curtail or limit manufacture.
40 (r) "Electronic prescription" means an electronically prepared
41 prescription that is authorized and transmitted from the prescriber to the
42 pharmacy by means of electronic transmission.
43 (s) "Electronic prescription application" means software that is used

HB 2366 17
1 to create electronic prescriptions and that is intended to be installed on the
2 prescriber's computers and servers where access and records are controlled
3 by the prescriber.
4 (t) "Electronic signature" means a confidential personalized digital
5 key, code, number or other method for secure electronic data transmissions
6 that identifies a particular person as the source of the message,
7 authenticates the signatory of the message and indicates the person's
8 approval of the information contained in the transmission.
9 (u) "Electronic transmission" means the transmission of an electronic
10 prescription, formatted as an electronic data file, from a prescriber's
11 electronic prescription application to a pharmacy's computer, where the
12 data file is imported into the pharmacy prescription application.
13 (v) "Electronically prepared prescription" means a prescription that is
14 generated using an electronic prescription application.
15 (w) "Facsimile transmission" or "fax transmission" means the
16 transmission of a digital image of a prescription from the prescriber or the
17 prescriber's agent to the pharmacy. "Facsimile transmission" includes, but
18 is not limited to, transmission of a written prescription between the
19 prescriber's fax machine and the pharmacy's fax machine; transmission of
20 an electronically prepared prescription from the prescriber's electronic
21 prescription application to the pharmacy's fax machine, computer or
22 printer; or transmission of an electronically prepared prescription from the
23 prescriber's fax machine to the pharmacy's fax machine, computer or
24 printer.
25 (x) "Intermediary" means any technology system that receives and
26 transmits an electronic prescription between the prescriber and the
27 pharmacy.
28 (y) "Isomer" means all enantiomers and diastereomers.
29 (z) "Manufacture" means the production, preparation, propagation,
30 compounding, conversion or processing of a controlled substance either
31 directly or indirectly or by extraction from substances of natural origin or
32 independently by means of chemical synthesis or by a combination of
33 extraction and chemical synthesis and includes any packaging or
34 repackaging of the substance or labeling or relabeling of its container,
35 except that this term does not include the preparation or compounding of a
36 controlled substance by an individual for the individual's own lawful use
37 or the preparation, compounding, packaging or labeling of a controlled
38 substance:
39 (1) By a practitioner or the practitioner's agent pursuant to a lawful
40 order of a practitioner as an incident to the practitioner's administering or
41 dispensing of a controlled substance in the course of the practitioner's
42 professional practice; or
43 (2) by a practitioner or by the practitioner's authorized agent under

HB 2366 18
1 such practitioner's supervision for the purpose of or as an incident to
2 research, teaching or chemical analysis or by a pharmacist or medical care
3 facility as an incident to dispensing of a controlled substance.
4 (aa) "Marijuana" means all parts of all varieties of the plant Cannabis
5 whether growing or not, the seeds thereof, the resin extracted from any
6 part of the plant and every compound, manufacture, salt, derivative,
7 mixture or preparation of the plant, its seeds or resin. It does not include:
8 (1) The mature stalks of the plant, fiber produced from the stalks, oil
9 or cake made from the seeds of the plant, any other compound,
10 manufacture, salt, derivative, mixture or preparation of the mature stalks,
11 except the resin extracted therefrom, fiber, oil or cake or the sterilized seed
12 of the plant that is incapable of germination;
13 (2) any substance listed in schedules II through V of the uniform
14 controlled substances act;
15 (3) drug products approved by the United States food and drug
16 administration as of the effective date of this act;
17 (4) cannabidiol (other trade name: 2-[(3-methyl-6-(1-methylethenyl)-
18 2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol); or
19 (5) industrial hemp as defined in K.S.A. 2-3901, and amendments
20 thereto, when cultivated, produced, possessed or used for activities
21 authorized by the commercial industrial hemp act.
22 (bb) "Medical care facility" shall have the meaning ascribed to that
23 term means the same as defined in K.S.A. 65-425, and amendments
24 thereto.
25 (cc) "Mid-level practitioner" means a certified nurse-midwife
26 engaging in the independent practice of midwifery under the independent
27 practice of midwifery act, an advanced practice registered nurse issued a
28 license pursuant to K.S.A. 65-1131, and amendments thereto, who has
29 authority to prescribe drugs pursuant to a written protocol with a
30 responsible physician under K.S.A. 65-1130, and amendments thereto, or a
31 physician assistant licensed under the physician assistant licensure act who
32 has authority to prescribe drugs pursuant to a written agreement with a
33 supervising physician under K.S.A. 65-28a08, and amendments thereto.
34 (dd) "Narcotic drug" means any of the following whether produced
35 directly or indirectly by extraction from substances of vegetable origin or
36 independently by means of chemical synthesis or by a combination of
37 extraction and chemical synthesis:
38 (1) Opium and opiate and any salt, compound, derivative or
39 preparation of opium or opiate;
40 (2) any salt, compound, isomer, derivative or preparation thereof that
41 is chemically equivalent or identical with any of the substances referred to
42 in paragraph (1) but not including the isoquinoline alkaloids of opium;
43 (3) opium poppy and poppy straw; or

HB 2366 19
1 (4) coca leaves and any salt, compound, derivative or preparation of
2 coca leaves, and any salt, compound, isomer, derivative or preparation
3 thereof that is chemically equivalent or identical with any of these
4 substances, but not including decocainized coca leaves or extractions of
5 coca leaves that do not contain cocaine or ecgonine.
6 (ee) "Opiate" means any substance having an addiction-forming or
7 addiction-sustaining liability similar to morphine or being capable of
8 conversion into a drug having addiction-forming or addiction-sustaining
9 liability. It does not include, unless specifically designated as controlled
10 under K.S.A. 65-4102, and amendments thereto, the dextrorotatory isomer
11 of 3-methoxy-n-methylmorphinan and its salts (dextromethorphan). It does
12 include its racemic and levorotatory forms.
13 (ff) "Opium poppy" means the plant of the species Papaver
14 somniferum l. except its seeds.
15 (gg) "Person" means an individual, corporation, government, or
16 governmental subdivision or agency, business trust, estate, trust,
17 partnership or association or any other legal entity.
18 (hh) "Pharmacist" means any natural person licensed under K.S.A.
19 65-1625 et seq., and amendments thereto, to practice pharmacy.
20 (ii) "Pharmacist intern" means: (1) A student currently enrolled in an
21 accredited pharmacy program; (2) a graduate of an accredited pharmacy
22 program serving such person's internship; or (3) a graduate of a pharmacy
23 program located outside of the United States that is not accredited and who
24 had successfully passed equivalency examinations approved by the board.
25 (jj) "Pharmacy prescription application" means software that is used
26 to process prescription information, is installed on a pharmacy's computers
27 and servers, and is controlled by the pharmacy.
28 (kk) "Poppy straw" means all parts, except the seeds, of the opium
29 poppy, after mowing.
30 (ll) "Practitioner" means a person licensed to practice medicine and
31 surgery, dentist, podiatrist, veterinarian, optometrist, naturopathic doctor
32 or scientific investigator or other person authorized by law to use a
33 controlled substance in teaching or chemical analysis or to conduct
34 research with respect to a controlled substance.
35 (mm) "Prescriber" means a practitioner or a mid-level practitioner.
36 (nn) "Production" includes the manufacture, planting, cultivation,
37 growing or harvesting of a controlled substance.
38 (oo) "Readily retrievable" means that records kept by automatic data
39 processing applications or other electronic or mechanized recordkeeping
40 systems can be separated out from all other records within a reasonable
41 time not to exceed 48 hours of a request from the board or other authorized
42 agent or that hard-copy records are kept on which certain items are
43 asterisked, redlined or in some other manner visually identifiable apart

HB 2366 20
1 from other items appearing on the records.
2 (pp) "Ultimate user" means a person who lawfully possesses a
3 controlled substance for such person's own use or for the use of a member
4 of such person's household or for administering to an animal owned by
5 such person or by a member of such person's household.
6 Sec. 8. K.S.A. 65-7201 is hereby amended to read as follows: 65-
7 7201. K.S.A. 65-7201 to through 65-7218, inclusive and amendments
8 thereto, and sections 1 through 5, and amendments thereto, shall be known
9 and may be cited as the naturopathic doctor licensure act.
10 Sec. 9. K.S.A. 2022 Supp. 65-7202 is hereby amended to read as
11 follows: 65-7202. As used in K.S.A. 65-7201 through 65-7218, and
12 amendments thereto the naturopathic doctor licensure act:
13 (a) "Naturopathic doctor" means a doctor of naturopathic medicine
14 who is authorized and licensed pursuant to this act.
15 (b) (1) "Naturopathic medicine," or "naturopathy" means a system of
16 health care practiced by naturopathic doctors for the prevention, diagnosis
17 and treatment of human health conditions, injuries and diseases, that uses
18 education, natural medicines and therapies to support and stimulate the
19 individual's intrinsic self-healing processes, and includes: (A) Prescribing,
20 recommending or administering: (i) Food, food extracts, vitamins,
21 minerals, enzymes, whole gland thyroid, botanicals, homeopathic
22 preparations, nonprescription drugs, plant substances that are not
23 designated as prescription drugs or controlled substances, topical drugs as
24 defined in subsection (i); (ii) health care counseling, nutritional counseling
25 and dietary therapy, naturopathic physical applications, barrier
26 contraceptive devices; (iii) substances on the naturopathic formulary that
27 are authorized for intramuscular or intravenous administration pursuant to
28 a written protocol entered into with a physician who has entered into a
29 written protocol with a naturopathic doctor licensed under the naturopathic
30 doctor licensure act; (iv) noninvasive physical examinations, venipuncture
31 to obtain blood for clinical laboratory tests and orofacial examinations,
32 excluding endoscopies; (v) minor office procedures; and (vi) naturopathic
33 acupuncture; and (B) ordering diagnostic imaging studies, including, but
34 not limited to, x-ray, ultrasound, mammogram, bone densitometry,
35 computed tomography, magnetic resonance imaging and
36 electrocardiograms, except that naturopathic doctors shall refer patients to
37 an appropriately licensed and qualified healthcare professional to conduct
38 diagnostic imaging studies and interpret the results of such studies.
39 (2) A naturopathic doctor may not perform surgery, obstetrics,
40 administer ionizing radiation, or prescribe, dispense or administer any
41 controlled substances as defined in K.S.A. 65-4101, and amendments
42 thereto, or any prescription-only drugs except those listed on the
43 naturopathic formulary adopted by the board pursuant to this act.

HB 2366 21
1 (c) "Board" means the state board of healing arts.
2 (d) "Approved naturopathic medical college" means a college and
3 program granting the degree of doctor of naturopathy or naturopathic
4 medicine that has been approved by the board under this act and which
5 college and program requires at a minimum a graduate-level, four-year,
6 full-time resident program of academic and clinical study.
7 (e) "Homeopathic preparations" means substances and drugs prepared
8 according to the official homeopathic pharmacopoeia recognized by the
9 United States food and drug administration.
10 (f) "Naturopathic acupuncture" means the insertion of fine metal
11 needles through the skin at specific points on or near the surface of the
12 body with or without the palpation of specific points on the body and with
13 or without the application of electric current or heat to the needles or skin
14 or both to treat human disease and impairment and to relieve pain.
15 (g) "Minor office procedures" means care incidental to and treatment
16 of superficial tissue, superficial lacerations and, abrasions, superficial and
17 lesions and, the removal of foreign bodies located in the superficial tissues,
18 except eyes, and not involving blood vessels, tendons, ligaments or nerves
19 not involving the eyes, nerves, veins or arteries extending beyond
20 superficial tissue. "Minor office procedures" includes use of antiseptics,
21 but shall not include the topical anesthesia and local anesthesia, but does
22 not include the suturing, repairing, alteration or removal of tissue or the
23 use of general or spinal anesthesia. Minor office procedures does not
24 include anesthetics or surgery.
25 (h) "Naturopathic physical applications" means the therapeutic use by
26 naturopathic doctors of the actions or devices of electrical muscle
27 stimulation, galvanic, diathermy, electromagnetic energy, ultrasound,
28 ultraviolet light, constitutional heat, air, hot or cold hydrotherapy,
29 naturopathic musculoskeletal technique and, therapeutic exercise and
30 treatments taught in any approved medical college that are not otherwise
31 prohibited by this act.
32 (i) "Topical drugs" means topical analgesics, antiseptics, scabicides,
33 antifungals and antibacterials but does not include prescription only drugs.
34 (j) "Physician" means a person licensed to practice medicine and
35 surgery.
36 (k) "Written protocol" means a formal written agreement between a
37 naturopathic doctor licensed under this act and a person licensed to
38 practice medicine and surgery. Any licensee of the board entering into a
39 written protocol with a licensed naturopathic doctor shall notify the board
40 in writing of such relationship by providing such information as the board
41 may require.
42 Sec. 10. K.S.A. 65-7207 is hereby amended to read as follows: 65-
43 7207. (a) The board shall charge and collect in advance fees provided for

HB 2366 22
1 in this act as fixed by the board by rules and regulations, subject to the
2 following limitations:
3 Application fee, not more than.............................................................. $200
4 Temporary license fee, not more than..................................................... $30
5 License renewal fee, not more than....................................................... $150
6 License late renewal additional fee, not more than............................... $250
7 License reinstatement fee, not more than.............................................. $250
8 Certified copy of license, not more than................................................. $30
9 Written verification of license, not more than......................................... $25
10 (b) The board shall charge and collect in advance fees for any
11 examination administered by the board under the naturopathic doctor
12 licensure act as fixed by the board by rules and regulations in an amount
13 equal to the cost to the board of the examination. If the examination is not
14 administered by the board, the board may require that fees paid for any
15 examination under the naturopathic doctor licensure act be paid directly to
16 the examination service by the person taking the examination.
17 Sec. 11. K.S.A. 65-7208 is hereby amended to read as follows: 65-
18 7208. (a) The board may deny, refuse to renew, suspend, revoke, place
19 under probationary conditions or limit a licensee's license or the licensee
20 may be publicly or privately censured where the licensee or applicant for
21 licensure has been guilty of unprofessional conduct which has endangered
22 or is likely to endanger the health, welfare or safety of the public.
23 Unprofessional conduct includes upon a finding that a licensee has:
24 (1) Obtaining Obtained a license by means of fraud,
25 misrepresentation or concealment of material facts;
26 (2) being guilty committed an act of unprofessional conduct as
27 defined by rules and regulations adopted by the board;
28 (3) being been convicted of a felony if the acts for which such
29 person was convicted are found by the board to have a direct bearing on
30 whether such person should be entrusted to serve the public in the capacity
31 of a naturopathic doctor;
32 (4) violating violated any lawful order or rule and regulation of the
33 board; and
34 (5) violating violated any provision of this the naturopathic doctor
35 licensure act;
36 (6) an adverse judgment, award or settlement rendered against the
37 licensee resulting from a professional liability claim related to acts or
38 conduct similar to acts or conduct that would constitute grounds for
39 disciplinary action under this section;
40 (7) failed to report to the board any adverse action taken against the
41 licensee by another state or licensing jurisdiction, a healthcare facility, a
42 professional association or society, a governmental agency, a law
43 enforcement agency or a court for acts or conduct similar to acts or

HB 2366 23
1 conduct that would constitute grounds for disciplinary action under this
2 section;
3 (8) prescribed or administered a prescription drug or substance,
4 including a controlled substance, in an improper or inappropriate manner,
5 or for other than a valid medical purpose, or not in the course of the
6 licensee's professional practice; and
7 (9) given a worthless check or stopped payment on a debit or credit
8 card for fees or moneys legally due to the board.
9 (b) Such denial, refusal to renew, suspension, revocation, probation
10 or limitation of a license or public or private censure of a licensee may be
11 ordered by the board after notice and hearing on the matter in accordance
12 with the provisions of the Kansas administrative procedure act. Upon the
13 end of the period of time established by the board for the revocation of a
14 license, application may be made to the board for reinstatement. The board
15 shall have discretion to accept or reject an application for reinstatement
16 and may hold a hearing to consider such reinstatement. An application for
17 reinstatement of a revoked license shall be accompanied by the license
18 renewal fee and the license reinstatement fee established under K.S.A. 65-
19 7207, and amendments thereto.
20 (c) The board, in addition to any other penalty prescribed in
21 subsection (a), may assess a civil fine, after proper notice and an
22 opportunity to be heard, against a licensee for unprofessional conduct in an
23 amount not to exceed $5,000 for the first violation, $10,000 for the second
24 violation and $15,000 for the third violation and for each subsequent
25 violation. All fines assessed and collected under this section shall be
26 remitted to the state treasurer in accordance with the provisions of K.S.A.
27 75-4215, and amendments thereto. Upon receipt of each such remittance,
28 the state treasurer shall deposit the entire amount in the state treasury to
29 the credit of the state general fund. Fines collected under this section shall
30 be considered administrative fines pursuant to 11 U.S.C. § 523.
31 Sec. 12. K.S.A. 65-7209 is hereby amended to read as follows: 65-
32 7209. (a) Licenses issued under this act shall expire on the date of
33 expiration established by rules and regulations of the board be canceled on
34 January 31 of each year unless renewed in the manner prescribed by the
35 board. The request for renewal shall be accompanied by the license
36 renewal fee established pursuant to K.S.A. 65-7207, and amendments
37 thereto. The board may establish additional requirements for license
38 renewal which that provide evidence of continued competency. The board
39 shall require as a condition for renewal of a license completion of at least
40 25 hours annually of continuing education approved by the board.
41 (b) At least 30 days before the expiration renewal date of a licensee's
42 license, the board shall notify the licensee of the expiration renewal date
43 by mail addressed to the licensee's last mailing address as noted upon the

HB 2366 24
1 office records. If the licensee fails to submit the renewal application and
2 pay the renewal fee by the date of expiration renewal date, the licensee
3 shall be given a second notice that the license has expired and the license
4 may be renewed only if the license licensee has failed to submit the
5 renewal application and pay the renewal fee by the renewal date of the
6 license and that the license will be canceled if not renewed within 30 days
7 following the renewal date. The notice shall also state that if the renewal
8 application, the renewal fee and the an additional late renewal fee
9 established by rules and regulations are received by the board within the
10 thirty-day 30-day period following the date of expiration cancellation, the
11 license will not be canceled and that, if both fees are not received within
12 the thirty-day 30-day period, the license shall be deemed canceled by
13 operation of law without further proceedings for failure to renew and shall
14 be reissued only after the license has been reinstated under subsection (c).
15 (c) Any license canceled for failure to renew as herein provided in
16 this section may be reinstated upon recommendation of the board and
17 upon, payment of the license reinstatement fee and upon submitting
18 evidence of satisfactory completion of any applicable continuing education
19 requirements established by the board. The board shall adopt rules and
20 regulations establishing appropriate continuing education requirements for
21 reinstatement of licenses canceled for failure to renew.
22 (d) A person whose license is suspended shall not engage in any
23 conduct or activity in violation of the order or judgment by which the
24 license was suspended.
25 Sec. 13. K.S.A. 65-7214 is hereby amended to read as follows: 65-
26 7214. (a) There is established a naturopathic advisory council to advise the
27 board in carrying out the provisions of this act. The council shall consist of
28 five members, all citizens and residents of the state of Kansas appointed as
29 follows: Three members shall be naturopathic doctors appointed by the
30 state board of healing arts; one member shall be the president of the state
31 board of healing arts or a person designated by the president; and one
32 member appointed by the governor shall be from the public sector who is
33 not engaged, directly or indirectly, in the provision of health services.
34 Insofar as possible persons appointed to the council shall be from different
35 geographic areas. If a vacancy occurs on the council, the appointing
36 authority of the position which that has become vacant shall appoint a
37 person of like qualifications to fill the vacant position for the unexpired
38 term, if any. The members of the council appointed by the governor shall
39 be appointed for terms of three years and until a successor is appointed.
40 The members appointed by the state board of healing arts shall serve at the
41 pleasure of the state board of healing arts. If a member is designated by the
42 president of the state board of healing arts, the member shall serve at the
43 pleasure of the president.

HB 2366 25
1 (b) Members of the council attending meetings of the council, or
2 attending a subcommittee meeting thereof authorized by the council, shall
3 be paid amounts provided in subsection (e) of K.S.A. 75-3223(e), and
4 amendments thereto, from the healing arts fee fund.
5 (c) During the 2003 regular session of the legislature the legislature
6 shall consider establishing an alternative health care board composed of
7 representatives as may be designated from existing health care regulatory
8 agencies, alternative health care providers and members of the general
9 public for purposes of advising the legislature on matters relating to
10 alternative health care, administering the naturopathic doctor registration
11 act and performing such other duties as may be established by law.
12 (d) The provisions of this section shall take effect on and after
13 January 1, 2003.
14 Sec. 14. K.S.A. 65-7201, 65-7207, 65-7208, 65-7209 and 65-7214
15 and K.S.A. 2024 Supp. 65-1626, 65-4101 and 65-7202 and K.S.A. 2024
16 Supp. are hereby repealed.
17 Sec. 15. This act shall take effect and be in force from and after its
18 publication in the statute book.

[DELETED: An; le ad rn of nc dbK2sBN0(1eg e, ad ly es fr d2p3t4(5r6m7d8h9t0(1n2t3s4bs t t s ; 5n6nc pl a, br ce ds a7ie i; () ss ad fr i8s, i, i, l, t9pr or ir a, ig p0t1m2(3d4a5(]
[DELETED: 6((aii((((m l, dy or ay pe ig t0r1(2(3(4s5(6o7p8(9(0a1N213(4e5i6d7(e oy wn te nc dr hs a8e9a0(1o2N3f4(5s6u7(s ld to ee in te pe of n8m9i0s1(2a3t]
[DELETED: 6t(lpNeDif0p1(2m3s4N5o6i7e8p9s0S1f2(3a4(5i6o7(8(9o0(1t2(3t4p5c6wn ag in te ul ad ll ce of te cs o7w8(9s0(1a2d3(]
[DELETED: 6((2(1(dsp0d1(2d3(d p" ms a pn or p4mr tt hs ed io an at wh a5p6in a bs a or on rd to te me o7d8(9d0d1(2c3(s t f s r 4i5c6i7a8(9a0(1an of r p d os bd o r2r3(4a5(6r7m8w9(0e1(" or "" ms te a, ce o2a3a]
[DELETED: 6(ci(S((i(0h1(2c3(4a5(6p7p8as ae p, pe pl a, dn a9a0f1(" or "" ms to dr p2m3l4p, i, bt nt ld t, dg p5m6t7(8(9d0o1t2(3u4d5(6s7o8d9i0a1(2d3(]
[DELETED: 6l(ee d, of te ms pn dg to awptdo(0(1s2f3(4p5(6t7(8p9ps or a, et tt te tm "" ds nt i0a1b2o3(4(5c6c7(8(9i0(1(2m3i4c5( ie ds ad ml ss or or s6e7b8(c p" ms an ey p9p0p1(2t3p]
[DELETED: 6b(ktt is a pr pn as te se of te maa(c t" ms te tn of aec s n c a , m p0w1(2i3(4d5d6w7(8s9(e t" or "x t" ms t0t1p2i3p4a5p6p7p8p9(0n1(2m3i4() (l dg r" ms ay ln w5p6a7p8(9(0f1(2c3(]
[DELETED: 6(((((pa(t0ps wh re pt ey ad by o1iy e" as mg te ss f2"3J4(5b6ur cn op or cl of a ce e, or a7t8(9u0(1t2o3d4(t s s 5o6o7r8(9K0(142p3a4(5c6i7b8e9r0t1by an il fr te is on ue or te p2c3(]
[DELETED: 6pp(pt(dd(0(1t233n4m5(6o7o8(9r0(1(2o3t4l5a6(l p" ms a cd n7e8p9l0a1t2l3a4a5(6K7(g f" ms a fy at oe g8l9h0U1(" ms i, c, g2g3l]
[DELETED: 61(p(trs of ts se pg to te pe of pmcbe0N1t2(3(4a5(a ge of an ad py pm sg a6i7(8S9e0(" "" or "" ms p1l2(e ds ae od fr se we te pn o3p4d5(6"l c" "" "" "7"8o9c0p1(2p3o4r5c6b7(8u9p0m1p2a3s]
[DELETED: 61(dmppn(so0p1r2(3to y' ee as a pt ad wo ss ad i4r5e6(7(8o9o0c1d2(3c4o5(6u7Ut a 8p9o0(1l2p3p4t5a6i7(8d930(1(e or me is ig fe to ae to t2a3g]
[DELETED: 61(sn(a(kefm al or rs q ad e dg an in o0i1w2(3o4(5t6(7ds tt ae p, f pd b te mr o8d9r0n1py d; or () a dg id fr hn ue b2h3(4et tt ds of or oe ps se o5n6t7s8(9(0c1c2b3t4(5(6f7a8r9a0(a t ls pr fm wm a m1r2a3d]
[DELETED: 61(w(((c(o(0(1o2(3a4(5(6p7(n of ay at of sl a, mt o8e9(0n1(2s3s4r5t6y7(8f9l0s1bs of an id qe or cn wt a2a3(4l5c6d7(8m9(s te nw dg an or ad nw d0a1(2p3(]
[DELETED: 61p(a((tp(e d" ms ay pn ed iw0t1(2d3w4i5(6(7o8e9a0n1m2(3(4o5c6(7d8o9o0(1e2o3(4rs l 5o6a7S8f9(" ms te dt an of a c0s1t2(3o]
[DELETED: 61(o(taw(n se p" ms an ey tt ses0t1(2(3U4(5p667(8i9(0t1s2t3(4o5d6c748(9o0e1d2c344(5(6(7o8(9i0f1r2(3c]
[DELETED: 61tlp(m(e(" or "" ms te a, ce oa0w1(2u3i4s5p6(7a8i9(0d1(2(3(s 4p5o6(s 7t8(9a0(s 1s2(3a4(5f6c7ie cl i u or l to be u in t8m9p0(c p" ms an ey p1p2p3(]
[DELETED: 61tpb(ktt is a pr pn as te se of te maa(0p1e2d3(4g5(e t" or "x t" ms t6t7p8i9p0a1p2p3p4p5(6ts an ec pn bn te pr ad t7p8(9(0c1d2i3en ad cl ss ad is ay pg o4r5e6c7o8s9(0o1d2p3(]
[DELETED: 61srf(wpm(or ce me fm te ss of te p, ay or c0m1e2o3(4c5(6a7(829(0t wn c, p, pd or ud fr a1a2(3t m i4t5(l p" ms a cd n6e7p8l9a to pe d pt to a wn pl wh a0r1p2h3s4(5d6i7e8(m ad oe ad ay s, c, de o9p0(1i2i3(]
[DELETED: 61(ctsc(acl0u1o2i3(m p" ms te pt of te ss P4s5(" ms an i, c, g, o6gl sn or a, bs t, e, t7p8(960(1a2p3p4h5(6t7a8(9p0(1s2o3c4r5(6(7g8(9p0s1t2a3a]
[DELETED: 62f(s s cosS7 t t 6 i ata0S. 1f.  K2a3(4w5(6h7a8e9i0rg or a: () F, fd e, v1m, e, we gd t, b, h2p, nn d, pt ss tt ae n3d4d5ad dy t, nc pl a, b6c7a8a9w0d1t2e3a4nt ld t, x, u, m, be d5cd t, mc e ig a6e7a8d9( nc dr my nt pm s, o0a1c2t, or ay py ds et te ld on t3n]
[DELETED: 62((pmcf(aU0(1n2b3o4o5(6o7l8e9nt ig te e, n, vs or as eg b0s1b2n3u M4i5(6nc ds of te as or ds of el m7s, g, d ec e u8u l c h, a, ht or c h9n a t a0t1p2(3a4(5s6(7n8p9w0i1m2S37]
[DELETED: 62ifATLLLCW0(1e2l3e4a5e6t7S879u0m1l2o3U4( a le by ms of f5m6( o7d8( c i9p0w1o2(3b4(5l6(7l8c9d0(1l2pl an or s, a gl a, a l3e]
[DELETED: 62cs(iol(c(0o1o2w3e4l5s6a7r8r970(e b, in an to ay or py pd i1ss l 2o3a4v5v6r778t9t0b1S27.  e3e4J5b6r7t8r9s021(2l3b]
[DELETED: 62opsm lrlfae  t a le0t1l2t t 3 p3o4b5(6t m a7u pd n 8e9r0r1r2(3c4l5S677b8f9f0s1b2m3n4I5ga 6a7p8t9b0T1p2p3p]
[DELETED: 62(abn f  aa(srap0a1a2(3J4S5a6S7S8p]